Oceania Healthcare Limited logo

Momentum Building on Stronger Foundations

Half Year Results20 November 2025OCAHealthcare

Interim Report 2026
Delivering

Better.

2
At a glance

3

Trading results

4

Letter from the Chair and CEO

8

Three year summary

9

Proforma Underlying Earnings

10

Consolidated Interim Financial Statements

Contents

1

Oceania

Interim Report 2026

“Our integrated model, offering residents a pathway from independent

living through rest home and hospital care to specialist dementia support,

continues to enable natural transitions and reinforces Oceania’s reputation

for quality and continuity of care.”

From Ruakaka in the
north, to Riccarton in

the south, we create

places where older

New Zealanders

can live with

purpose, dignity

and connection.

StaffResidents

Care beds and care suitesUnits

At a glance

Existing sites with

mature operations

Existing sites

with current and

planned developments

Total sites

191736

~2,600~3,9 0 0

2,1511,9 8 8

As at 30 September 2025

Section Title / Article Title

2

Oceania

Interim Report 2026

A year in review

2

Highlights
Developments

30 September 2025

Additional units and care suites expected to be completed in FY26

• Franklin Stage 1 (Auckland)

31

Units and care suites completed in 1HY26

• Meadowbank Stage 6 (Auckland)

40

Financial

30 September 2025

Total assets

As at 30 September 2025

Consistent with 31 March 2025

total assets of $2.9bn.

20%241%12%

Proforma Underlying Earnings

Before Interest, Tax, Depreciation

and Amortisation

30 September 2025

$

41.8 m

$

3.0bn

$

40.4m

$

7 9.0 m

Ahead of 30 September 2024 Proforma

Underlying Earnings Before Interest, Tax,

Depreciation and Amortisation of $34.9m.

Reported Total

Comprehensive Income

30 September 2025

$28.6m higher than 6 months to

30 September 2024 reported total

comprehensive income of $11.8m.

Operating Cash Flow

30 September 2025

Higher than 6 months to

30 September 2024 reported

operating cashflow of $70.4m.

Operational

30 September 2025

0.2%

94.7

%

Compared to occupancy for

the year to 31 March 2025

of 94.5%.

(excluding development sites)

Total sales

Higher than total sales for the six

months 30 September 2024 of 258.

5%

52109

271

3971

New care suites

Resale

care suites

Care Occupancy

New unitsResale units

For the six month period

ended 30 September 2025

Oceania

Interim Report 2026

3

Trading highlights

Building momentum off strengthened foundations
Welcome to our Interim Report for the six months ended

30 September 2025 (1HY26), a period of strengthening

foundations while staying true to what differentiates

Oceania: trusted care and high quality living.

The three priorities presented at our September Investor Day

(sales performance, business excellence and capital management)

are being executed through sales initiatives, cost reduction and

divestments. The outcome is growing sales momentum at key sites,

improved operating cashflow and a clear path to lower debt.

Highlights

Financial and Operating Performance

1

• Total Comprehensive Income: $40.4m, up $28.6m on 1HY25 largely

due to positive fair value movements on property valuations

• Proforma

2

Underlying EBITDA from core continuing operations:

$41.8m, a 19.7% increase from 1HY25

• Proforma

2

Underlying NPAT from core continuing operations:

$24.1m, a 18.9% increase from 1HY25

• Free Cash Flow from Operations

3

: ($8.4m), a 30.0% improvement

from 1HY25

• Cost reduction programme: $20.4 million in annualised savings

identified; $4.0m delivered in 1HY26, $13.2m on track to be

delivered in FY26

• Annualised

4

Care EBITDA per bed excluding resale gains:

increased 45.5% to $12,400 per bed

Suzanne Dvorak

– Chief Executive Officer

Elizabeth Coutts

– Chair

1

All metrics and financial results included in the Chair and CEO letter are extracted from the interim financial

statements and are unaudited.

2

Proforma metrics exclude Wesley Institute of Nursing Education, which was closed during April 2025.

3

Free cash flow from operations is calculated as cash flows from ongoing operations including realised Deferred

Management Fees and Capital Gains from resale of ORA contracts, less maintenance capital expenditure and

finance costs on core debt (excluding development debt).

4

Annualised relates to the 12 month rolling period to 30 September 2025.

Our first residents will move into Franklin Village, Pukekohe (Auckland) in January 2026.

4

Oceania

Interim Report 2026

Letter from the Chair and CEO

Sales and Development Performance
• The Helier, Auckland: 54.5% occupied and under application

on 20 November 2025, full development cash recovery after

interest expense expected by 31 March 2026

• 40 care suites at Meadowbank were delivered in 1HY26

• Franklin, Auckland: 31 villas and community lodge on track to

welcome residents in January 2026 with 11 presales secured

to date

Capital Management

• Total assets increased to $3.0b, up $96.9m from FY25.

• Net tangible assets: $1.57 per share, a 3.8% increase on FY25

• Gearing: 34.8%, down 1.5 percentage points from

31 March 2025 and within the targeted range of 30 – 35%

• A further four sites are in the process of being divested,

expected to release $40m of capital during FY26.

Financial performance

Oceania delivered a solid underlying result despite a

persistently challenging residential property market and tough

economic conditions.

• Normalising for the closure of the Wesley Institute of Nursing

Education, Proforma

1

Underlying EBITDA from core continuing

operations increased 19.7% on the prior comparative period

(pcp), reflecting improved care margins, reduced overhead

costs and disciplined operational execution.

Proforma

1

Underlying Net Profit After Tax was $24.1m, 18.9% up on

1HY25 largely due to interest on completed developments being

expensed and not capitalised.

Free Cash Flow from Operations was ($8.4m), improved 30.0%

on 1HY25, driven by improved sales conversion and disciplined

working capital management.

As a result of the sales and operating improvements, the debt

gearing ratio has reduced to 34.8% from the peak at 38.3% in

FY24, now within the targeted gearing range of 30 – 35%.

Sales and Development performance

Going into this period, the business sought to improve sales

cadence to reduce unsold stock and in turn net debt. Following

several sales initiatives, sales momentum has been positive

across key sites, with strong development sales in the period (39

independent living units and 52 care suites) alongside solid resales

performance (71 independent living units and 109 care suites).

At The Helier in Auckland, sales are progressing well, with

54.5% of residences occupied or under application as at

20 November 2025. Based on current sales, we expect The Helier to

reach full development cash recovery, including interest expense,

by 31 March 2026. At Franklin in Auckland, construction is on

schedule with the completion of The Lodge and the first stage of 31

villas set to welcome the first residents in January 2026. Presales

continue to build, with 11 villas presold. The adjoining 3.7 hectare

land purchase in September 2025 expands the site to 11.6 hectares

and provides flexibility for future staged development. The project

exemplifies a disciplined approach to greenfield development.

The pleasing level of presales demonstrates the strength of

our sales capability and the appeal of the Franklin offering.

It highlights that the right product in the right location drives

success and has contributed to the growing positive momentum

across the business. The independent villa delivery at Franklin

and the 40 care suites at Meadowbank delivered in 1HY26

contribute to a forecast development delivery of 71 units and

care suites for FY26. We currently expect to build toward our

annual development target range of 100-150 units over the

coming years.

Across the portfolio, focused management of unsold stock and

village led marketing has achieved a reduction in vacant stock

from $392m in FY25 to $353m at 1HY26.

Total sales volume increased 5% to 271 units, with care suite

sales particularly strong at 161 units, which demonstrates the

demand for Oceania’s premium care offering.

1

Proforma Underlying operations excludes earnings from the Wesley Institute of Nursing Education,

which was closed during April 2025.

5

Oceania

Interim Report 2026

Letter from the Chair and CEO

Care profitability
Our care offering remains at the centre of Oceania’s purpose

and performance. Enhanced clinical systems, digital tools and

refined acuity management are both strengthening care delivery

for our residents and supporting margin improvement for our

business. As a result, care segment Underlying EBITDA increased

40% compared with 1HY25 and annualised Care EBITDA per bed,

excluding resale gains, increased 45.5% to $12,400, with 53% of

the portfolio generating more than $15,000 per bed per annum.

Care occupancy across sites not impacted by development

reached 94.7 %, up from 94.0% in 1HY25.

Our integrated model, offering residents a pathway from

independent living through rest home and hospital care to

specialist dementia support, continues to support natural

transitions and reinforces Oceania’s reputation for quality

and continuity of care.

Strategy

The strategy announced in September 2025 set clear near-term

priorities for FY25 to FY27 and longer term objectives for FY27

to FY31.

Current initiatives in Sales Performance, Business Excellence and

Capital Management are laying the groundwork for the long term,

when we will focus on Customer Choice, Service Expansion and

Future Development.

As the business moves from strengthening the balance sheet

to scaling its integrated model, development will remain

aligned with market conditions and capital availability. This

approach is already evident at Franklin, where early sales

success demonstrates the benefits of staging. The land bank

provides capacity for approximately 1,000 additional units

and care suites across consented and planned projects,

offering flexibility across product types including care suites,

independent villas and higher density apartments with the

development mix tailored to site characteristics, market

demand and capital efficiency.

Development delivery will be paced through FY27 and FY28 to

build to the target of 100 to 150 units per annum. Reflecting

improved operating cashflows and moderating development,

gearing has been managed into the targeted range of 30

– 35%, 34.8% at 30 September 2025, down from a peak of

38.3% in FY24.

Sustainability and climate

Oceania remains committed to operating responsibly and

minimising environmental impact. Climate considerations have

been further integrated into development planning and asset

management. Progress continues against emissions reduction

targets through energy efficient design standards, improved

waste diversion and energy management across the portfolio.

The Sustainable Finance Framework links the cost of debt to

environmental performance, providing both accountability

and incentive for continued improvement.

Oceania’s sustainability leadership was also recognised at

the annual Aged Care Association Conference, where our

Eversley community in the Hawkes Bay received both the

Sustainability Award and the overall Excellence in Care Award.

This recognition further reinforces Oceania’s position as a

leader in sustainable, resident-centred care.


$$

41.8m

Proforma Underlying EBITDA

20% higher than 6 months

to 30 September 2024

of $34.9m

6

Oceania

Interim Report 2026

Our people
The professionalism and care of Oceania’s 2,600 team members

continue to define the organisation. Their resilience and

commitment during a period of strategic change have ensured

quality and consistency for residents and families. Investment

continues in leadership development, workplace culture and

a compelling employee value proposition to retain and attract

talent in a competitive labour market.

Dividend

The Board announced a new dividend policy in June 2025 to align

with operating cashflows and targeting a payout ratio of between

40 and 60% of free cashflow from operations, subject to capital

requirements and investment opportunities. The Board has decided

not to declare an interim dividend for 1HY26, in line with the policy.

Dividend payments are expected to resume when the business

achieves positive free cash flow from operations, supporting a

return to payment of dividends.

Outlook

Demographic demand for high quality care and retirement

living remains strong and structural, with demand continuing to

outstrip supply in key markets. The broader housing market has

constrained our residents’ ability to sell their family homes over

recent times, acting as a handbrake on sales. However, once the

housing market cycle starts to improve, we expect the strong

demographic drivers to return to the fore.

Elizabeth Coutts

Chair

Suzanne Dvorak

Chief Executive Officer

The focus for the second half is clear: accelerating the sell down

of stock, progressing the divestment programme, continuing to

execute cost efficiencies, and further improving care profitability.

Disciplined execution against these priorities will position Oceania

to deliver long term value for shareholders, residents and staff.

We thank shareholders for their ongoing support, residents and

their families for choosing Oceania, and our teams for their

commitment to care excellence and operational discipline.

The Lodge will be completed as part of stage one of the Franklin development in Pukekohe (Auckland).

7

Oceania

Interim Report 2026

Letter from the Chair and CEO

Financial Metrics
$NZm

Unaudited

September 25

Unaudited

September 24

Unaudited

September 23

Total Comprehensive Income40.411.861.7

Profit / (Loss) for the Period4.9(17.1)35.2

Total Assets 3,037.62,821.22,689.8

Net Debt 608.9628.9616.7

Operating Cash Flow79.070.457.2

Underlying Metrics

$NZm

Unaudited

September 25

Unaudited

September 24

Unaudited

September 23

Underlying Net Profit after Tax

1

23.824.027.4

Underlying EBITDA

1

41.5 38.637.6

Proforma Underlying Net Profit After Tax

2

24.120.324.5

Proforma Underlying EBITDA

2

41.834.934.7

Operating Metrics

Unaudited

September 25

Unaudited

September 24

Unaudited

September 23

Units1,988 1,9151,887

Care Suites1,1231,091984

Care Beds1,0281,1181,396

Total4,1394,1244,267

New Sales91 8984

Resales180169171

Total271258255

Occupancy 91.9%91.6%90.3%

Occupancy (excluding development sites)94.7%94.0%92.2%

Three year summary

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

1

This is a non-GAAP measure, refer to note 2.1 in the consolidated interim financial statements for further details.

2

Proforma amounts represent earnings adjusted for the closure of the Wesley Institute of Nursing Education which ceased trading in the period.

Refer to Note 1.3 for further details.

Waterford, Auckland

8

Oceania

Interim Report 2026

Proforma Underlying Earnings
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

With changes to the certification pathways for overseas nurses introduced in 2025, a decision was made during

the year ended 31 March 2025 to close the Wesley Institute of Nursing Education. The final course was run in

April 2025. We show here the Underlying Earnings attributed to this business unit over the current and prior

comparative periods.

We present Proforma Underlying Earnings Before Interest and Tax and Underlying Net Profit Before Tax for both

periods, normalising for the impact of closing this operation from our ongoing operations.

$NZ000’sSeptember 25

Wesley Institute

of Nursing

Education

Proforma

September 25September 24

Wesley Institute

of Nursing

Education

Proforma

September 24

Care12,037-12,0378,570-8,570

Village44,896-44,89645,670-45,670

Other(15,424)333(15,091)(15,593)(3,700)(19,293)

Underlying EBITDA 41,50933341,84238,647(3,700)34,947

Underlying net profit after tax23,78333324,11623,978(3,700)20,278

The Bellevue, Christchurch

9

Oceania

Interim Report 2026

Consolidated interim
financial statements.

11

Consolidated Statement of Comprehensive Income

11

Consolidated Balance Sheet

12

Consolidated Statement of Changes in Equity

12

Consolidated Cash Flow Statement

13

Notes to the Consolidated Financial Statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

10

Oceania

Interim Report 2026

Consolidated Statement of Comprehensive Income
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

Consolidated Balance Sheet

AS AT 30 SEPTEMBER 2025

The above Consolidated Balance Sheet should be read in conjunction with the accompanying notes.The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.

The Board of Directors of the Company authorised these consolidated interim financial statements for issue on 21 November 2025.

For and on behalf of the Board

Elizabeth Coutts Alan Isaac

Chair Director

$NZ000’sNotes

Unaudited

Six Months

September 25

Unaudited

Six Months

September 24

Revenue

1

131,632132,605

Change in fair value of investment property

3.122,90326,140

Other income 1,3733,582

Total income155,908162,327

Employee benefits and other staff costs90,54590,626

Depreciation (buildings and care suites)

3.28,0386,904

Depreciation and amortisation (chattels, leasehold improvements and software)

3.23,8563,422

(Reversal of impairment) / Impairment of property, plant and equipment and

right of use asset

3.2(2,179)25,965

Impairment of held for sale assets

3.3-14

Impairment of goodwill87198

Finance costs13,97911,848

Other expenses40,55942,859

Total expenses

1

154,885181,836

Profit / (Loss) before income tax1,023(19,509)

Income tax benefit 3,9192,445

Profit / (Loss) for the period

1

4,942(17,064)

Other comprehensive income

Items that will not be subsequently reclassified to profit or loss

Gain on revaluation of property, plant and equipment for the period, net of tax

3.235,84630,137


Items that may be subsequently reclassified to profit or loss

Loss on cash flow hedges, net of tax(395)(1,231)

Other comprehensive income for the period, net of tax35,45128,906


Total comprehensive income for the period attributable to shareholders of

the parent40,39311,842

Basic earnings per share (cents per share)

4.20.7(2.4)

Diluted earnings per share (cents per share)

4.20.7(2.4)

$NZ000’sNotes

Unaudited

September 25

Audited

March 25

Assets

Cash and cash equivalents8,620 7,589

Trade and other receivables

5.1113,251117,791

Derivative financial instruments187 735

Assets held for sale

3.3- -

Investment property

3.12,034,3281,972,033

Property, plant and equipment

3.2868,047828,486

Right of use assets8,8839,341

Intangible assets4,2414,713

Total assets3,037,5572,940,688

Liabilities

Trade and other payables48,03236,445

Deferred management fee

3.455,36357,279

Refundable occupation right agreements

3.41,171,166 1,106,813

Lease liabilities10,17810,558

Borrowings

4.3610,073627,748

Total liabilities1,894,8121,838,843

Net assets1,142,7451,101,845

Equity

Contributed equity

4.1715,960715,960

Retained earnings12,6136,999

Reserves414,172378,886

Total equity1,142,7451,101,845


1

September 2025 includes revenue of nil, operating expenses of $0.6m, and a loss for the period of $0.6m in relation to the Wesley Institute of Nursing Education

(September 2024: revenue of $5.3m, operating expenses of $1.6m and profit for the period of $3.7m).

11

Oceania

Interim Report 2026

Consolidated Statement of Changes in Equity
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

Consolidated Cash Flow Statement

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes. The above Consolidated Cash Flow Statement should be read in conjunction with the accompanying notes.

$NZ000’sNotes

Contributed

equity

Retained

(deficit) /

earnings

Asset

revaluation

reserve

Cash flow

hedge

reserveTotal equity

Balance as at 1 April 2024 (audited) 715,960(34,264)342,5612,1991,026,456

Loss for the period-(17,064)--(17,064)

Other comprehensive income

Revaluation of cash flow hedge net of tax---(1,231)(1,231)

Revaluation of assets net of tax

3.2--30,137-30,137

Transfer of assets net of tax-9,955(9,955)--

Total comprehensive income-(7,109)20,182(1,231)11,842

Transactions with owners

Employee share scheme

4.1-338--338

Total transactions with owners-338--338

Balance as at 30 September 2024 (unaudited)715,960(41,035)362,7439681,038,636

Balance as at 1 April 2025 (audited)715,9606,999378,3325541,101,845

Loss for the period-4,942--4,942

Other comprehensive income

Revaluation of cash flow hedge net of tax---(395)(395)

Revaluation of assets net of tax

3.2--35,846-35,846

Transfer of assets net of tax-165(165)--

Total comprehensive income-5,10735,681(395)40,393

Transactions with owners

Employee share scheme

4.1-507--507

Total transactions with owners-507--507

Balance as at 30 September 2025 (unaudited)715,96012,613414,0131591,142,745

$NZ000’s

Unaudited

Six months

September

2025

Unaudited

Six months

September

2024

Cash flows from operating activities

Receipts from residents for village and care fees98,197106,022

Payments to suppliers and employees(124,567)(129,433)

Receipts from new occupation right agreements156,774168,101

Payments for outgoing occupation right agreements(56,252)(70,696)

Net goods and services tax received

1

12,197148

Receipts from insurance proceeds3864,374

Interest received6301,832

Interest paid in relation to general borrowings (7,965)(9,603)

Interest paid in relation to right of use assets(369)(393)

Net cash inflow from operating activities79,03170,352

Cash flows from investing activities

Payments for property, plant and equipment and intangible assets(9,024)(29,162)

Payments for investment property and investment property under

development(44,147)(45,645)

Proceeds from sale of assets1,52523,370

Interest paid in relation to development borrowings(6,368)(10,277)

Payments for assets held for sale-(439)

Net cash outflow from investing activities(58,014)(62,153)

Cash flows from financing activities

Proceeds from borrowings34,53162,344

Repayment of borrowings(52,596)(64,395)

Principal payments for lease liabilities(1,113)(606)

Loan refinancing fees(808)-

Net cash inflow from financing activities(19,986)(2,657)

Net increase in cash and cash equivalents1,0315,542

Cash and cash equivalents at the beginning of the period7,5897,485

Cash and cash equivalents at end of period8,62013,027

1

Net goods and services tax received includes $14.0m of GST recovered on development expenditure (Sept 24: nil).

12

Oceania

Interim Report 2026

1.General information14
1.1Basis of Preparation14

1.2Accounting Policies15

1.3Significant Events and Transactions15

1 .4Deferred Tax15

1.5Market Capitalisation15

2.Operating Performance16

2.1Operating Segments16

3.Property Assets21

3.1Village Assets: Investment Property22

3.2Care Assets: Property, Plant and Equipment24

3.3Held for Sale26

3.4Refundable Occupation Right Agreements27

4.Shareholder Equity and Funding27

4.1Shareholder Equity and Reserves27

4.2Earnings per Share29

4.3Borrowings30

5.Other Disclosures31

5.1Trade and Other Receivables31

5.2Contingencies and Commitments32

5.3Events After Balance Date32

Independent Auditor's Report33

Notes to the Consolidated

Interim Financial Statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

13

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

1. General Information

1.1 Basis of Preparation

(i) Entities Reporting

The consolidated interim condensed financial statements (“consolidated interim financial

statements”) of the Group are for the economic entity comprising Oceania Healthcare Limited

(the “Company”) and its subsidiaries (together “the Group”).

The consolidated interim financial statements incorporate the assets and liabilities of all

subsidiaries of Oceania Healthcare Limited as at 30 September 2025 and the results of all

subsidiaries for the six months then ended.

The Group owns and operates various care centres and retirement villages throughout

New Zealand. The Group’s registered office is Level 26, HSBC Tower, 188 Quay Street, Auckland,

1010, New Zealand.

(ii) Statutory Base

Oceania Healthcare Limited is a limited liability company which is domiciled and incorporated

in New Zealand. It is registered under the Companies Act 1993 and is a FMC Reporting Entity in

terms of Part 7 of the Financial Markets Conduct Act 2013. The Company is also listed on the NZX

Main Board (“NZX”) and the Australian Securities Exchange (“ASX”) as a foreign exempt listing. The

consolidated interim financial statements have been prepared in accordance with the requirements

of the NZX and ASX listing rules, and Part 7 of the Financial Markets Conduct Act 2013.

The consolidated interim financial statements have been prepared in accordance with New Zealand

Generally Accepted Accounting Practice (“NZ GAAP”). They also comply with NZ IAS 34 – Interim

Financial Reporting, IAS 34 – Interim Financial Reporting and other applicable New Zealand

Financial Reporting Standards, as appropriate for for-profit entities. They do not include all the

notes of the type normally included in the consolidated annual financial statements. Accordingly,

these consolidated interim financial statements are to be read in conjunction with the consolidated

annual financial statements for the year ended 31 March 2025, prepared in accordance with

New Zealand Equivalents to International Financial Reporting Standards (“NZ IFRS”). The Group

is a Tier 1 for-profit entity in accordance with XRB A1.

The accounting policies that materially affect the measurement of the Consolidated Statement of

Comprehensive Income, Consolidated Balance Sheet and the Consolidated Cash Flow Statement

have been applied on a basis consistent with those used in the audited consolidated financial

statements for the year ended 31 March 2025.

The consolidated interim financial statements for the six months ended 30 September 2025 and

comparatives for the six months ended 30 September 2024 are unaudited. The consolidated

annual financial statements for the year ended 31 March 2025 were audited and form the basis

for the comparative figures for that period in these statements. They are presented in New Zealand

dollars which is the Group’s presentation currency.

The consolidated interim financial statements have been prepared in accordance with the

going concern basis of accounting, which assumes that the Group will be able to realise its

assets and discharge its liabilities in the normal course of business as they come due into the

foreseeable future.

The Consolidated Balance Sheet has been prepared using a liquidity format.

(iii) Measurement Basis

These consolidated interim financial statements have been prepared under the historical cost

convention, as modified by the revaluation of certain assets and liabilities, including investment

properties, certain classes of property, plant and equipment and derivatives.

(iv) Key Estimates and Judgements

The preparation of the consolidated interim financial statements in conformity with NZ IFRS

requires the use of certain critical accounting estimates. It also requires management to exercise

their judgement in the process of applying the Group’s accounting policies.

The Group makes estimates and assumptions concerning the future. The resulting accounting

estimates will, by definition, seldom equal the related actual results. Estimates and judgements

are continually evaluated and are based on historical experience and other factors, including

expectations of future events that are believed to be reasonable under the circumstances.

The areas involving a higher degree of judgement or complexity, or areas where assumptions

and estimates are significant to the consolidated interim financial statements are disclosed in the

following notes:

• Classification of accommodation with a care or service offering (note 3)

• Fair value of investment property and investment property under development (note 3.1)

• Fair value of freehold land and buildings (note 3.2)

• Classification and fair value of held for sale facilities (note 3.3)

• Revenue recognition of deferred management fees (note 3.4)

14

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

1.2 Accounting Policies

(i) New Accounting Standards

No changes to accounting policies have been made during the year and the Group has not

early adopted any standards, amendments or interpretations to existing standards that are not

yet effective.

In May 2024 the External Reporting Board issued NZ IFRS 18: Presentation and Disclosure in

Financial Statements (‘NZ IFRS 18’), effective for reporting periods commencing on or after

1 January 2027. This accounting standard is expected to change the presentation of the Group’s

Statement of Comprehensive Income and may introduce additional note disclosures. NZ IFRS 18

does not impact the financial position, financial performance or cash flows of the Group. Other

standards, amendments and interpretations which are not yet effective are not expected to have

a material impact on the Group.

(ii) Measurement of Fair Value

The Group classifies its fair value measurement using the fair value hierarchy that reflects the

significance of the inputs used in making the measurements. The fair value hierarchy has the

following levels.

Level 1: Quoted prices (unadjusted) in active markets for the identical assets or liabilities.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the

asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).

Level 3: Inputs for the asset or liability that are not based on observable market data

(unobservable inputs).

The carrying amount of all financial assets and liabilities is considered to approximate

their fair value.

1.3 Significant Events and Transactions

(i) Disposal of assets

During the six months to 30 September 2025, the Woburn care centre located in Waipukurau was

sold for $1.8m.

(ii) Closure of Wesley Institute of Nursing Education

With change to the certification pathways for overseas nurses introduced in New Zealand,

a decision was made during the year ended 31 March 2025 to close the Wesley Institute of Nursing

Education. The final course concluded in April 2025.

The Wesley Institute of Nursing Education contributed $0.6m of operating expenses and EBITDA

of ($0.6m) in the current period. During the comparative period it contributed revenues of $5.3m,

operating expenses of $1.6m and EBITDA of $3.7m.

1.4 Deferred Tax

Tax losses are calculated annually on year end balances. As at 31 March 2025 the Group had an

estimated $355.3m of available tax losses.

The Group may recognise deferred tax assets to the extent that it is probable that the Group will

generate future economic profits to offset the deferred tax assets or to the extent that they offset

deferred tax liabilities. As at 31 March 2025 the Group recognised a deferred tax asset of $48.8m

representing tax losses generated in order to offset the net deferred tax liability position. All other

available losses generated are held off balance sheet.

As such the Group holds a neutral deferred tax position as at 30 September 2025.

1.5 Market Capitalisation

At balance date, the market capitalisation of the Group (being the 30 September 2025 closing

share price, as quoted on the NZX Main Board, multiplied by the number of shares on issue) was

below the carrying amount of the Group’s net assets and shareholders’ funds. In considering the

difference, the Group notes that over 90% of total assets at 30 September 2025 are property

assets carried at fair value as assessed by CBRE Limited.

15

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

2. Operating Performance

2.1 Operating Segments

The Group’s chief operating decision maker is the Board of Directors.

The operating segments have been determined based on the information reviewed by the Board

of Directors for the purposes of allocating resources and assessing performance. The assets

and liabilities of the Group are reported to the chief operating decision maker in total not by

operating segment.

The Group operates in New Zealand and comprises three segments; care operations, village

operations and other.

Information regarding the operations of each reportable segment is included above. Amongst

other criteria, performance is measured based on segmental underlying earnings before interest,

tax, depreciation and amortisation (“EBITDA”), which is the most relevant measure in evaluating

the performance of segments relative to other entities that operate within the aged care and

retirement village industries.

Additional segmental reporting information

Capital expenditure: Refer to note 3 for details on capital expenditure.

Goodwill: Goodwill is allocated to care cash generating units.

What is Total Comprehensive Income?

Total comprehensive income is a measure of the total performance of all segments under

NZ GAAP. It includes fair value movements relating to the Group’s care centres and cash

flow hedges.

16

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

CareVillageOther

Recognition

of Fair Value

movements on

Existing Care

Centres and

Retirement

Villages

Fair value movements are treated

the same as above.

When sites are decommissioned

for development this results in an

impairment of the buildings and

chattels which is recognised in

comprehensive income (i.e. profit

or loss).

Fair value movements are

recognised in comprehensive

income (i.e. profit or loss).

N/A

Recognition in

Underlying Profit

(refer note 2.1

overleaf)

Fair value movements are

removed.

Fair value movements are

removed. Realised gains on

resales and the development

margins from the sale of

independent living units and care

suites are included, reflective

of the ownership structure of

the assets.

No material adjustments.

Asset

Categorisation

Assets used, or, in the case of

developments, to be used, in the

provision of care are recognised

as property, plant and equipment.

Assets used, or, in the case of

developments, to be used, for

village operations are recognised

as investment property.

Corporate office assets are

recognised as property, plant

and equipment. Assets include

intangibles (e.g. software).

2.1 Operating Segments (continued)

CareVillageOther

ProductIncludes traditional care beds and

care suites.

Includes independent living and

rental properties.

N/A

ServicesThe provision of accommodation,

care and related services to

Oceania’s aged care residents.

Includes the provision of services

such as meals and care packages

to independent living residents.

The provision of accommodation

and related services to

independent residents in the

Group’s retirement villages.

Provision of support services to the

Group (includes administration,

marketing and operations).

In the comparative period this

segment includes the provision of

training by the Wesley Institute of

Nursing Education.

1


Recognition

of Operating

Revenue and

Expenses

The Group derives Operating

Revenue from the provision of care

and accommodation.

In relation to the provision of

superior accommodation above

the Government specification

the Group derives revenue

from Premium Accommodation

Charges (“PACs”) or, in the case

of care suites, through Deferred

Management Fees (“DMF”).

Operating Expenses primarily

include staff costs, resident

welfare expenses and overheads.

The Group derives Operating

Revenue from weekly service fees

and rental income. Operating

Revenue also includes DMF

accrued over the expected

occupancy period for the relevant

accommodation.

Operating Expenses include

village property maintenance,

sales and marketing, and

administration related expenses.

Includes corporate office and

corporate expenses.

Finance costs relate to the cost of

bank debt.

Income and expenditure relating

to the Wesley Institute of Nursing

Education is recognised in this

segment.

1


Recognition

of Fair Value

movements

on New

Developments

Fair value increases or decreases

are recognised in other

comprehensive income (i.e. not

in profit or loss) for the fair value

movement above historical cost.

Impairments below historical cost

are recognised in comprehensive

income (i.e. profit or loss).

Fair value movements are

recognised in comprehensive

income (i.e. profit or loss).

N/A

1

As a result of changes to the certification pathways for overseas nurses, a decision was made during the year ended 31 March 2025 to close the Wesley Institute

of Nursing Education. The final course concluded in April 2025.

17

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

2.1 Operating Segments (continued)

Six Months Ended 30 September 2025 (unaudited)

Care

Operations

Village

OperationsOther

1

Total

Revenue 102,87528,757 - 131,632

Change in fair value of investment property - 22,903 - 22,903

Other income4363007743

Total income103,31151,9607155,278

Operating expenses(91,735)(22,930)(16,439)(131,104)

Impairment of goodwill(87) - - (87)

Impairment of property, plant and equipment2,179- - 2,179

Segment EBITDA13,66829,030(16,432)26,266

Interest income--630630

Finance costs - - (13,979)(13,979)

Depreciation (buildings and care suites)(7,562)-(476)(8,038)

Depreciation and amortisation (chattels, leasehold

improvements and software)(2,889)-(967)(3,856)

Profit/ (Loss) before income tax3,21729,030(31,224)1,023

Income tax benefit4,073-(154)3,919

Profit/ (Loss) for the period attributable to shareholders7,29029,030(31,378)4,942

Other comprehensive income

Gain on revaluation of property, plant and equipment for the

period, net of tax35,846 - - 35,846

Loss on cash flow hedges, net of tax - - (395)(395)

Total comprehensive income / (loss) for the period

attributable to shareholders of the parent43,13629,030(31,773)40,393

Six Months Ended 30 September 2024 (unaudited)

Care

Operations

Village

OperationsOther

2

Total

Revenue 100,50026,7585,347132,605

Change in fair value of investment property - 26,140 - 26,140

Other income4271,32211,750

Total income100,92754,2205,348160,495

Operating expenses(92,358)(20,186)(20,941)(133,485)

Impairment of goodwill(198) - - (198)

Impairment of property, plant and equipment(25,965) - - (25,965)

Impairment of held for sale assets-(14)-(14)

Segment EBITDA(17,594)34,020(15,593)(833)

Interest income-3261,5061,832

Finance costs - - (11,848)(11,848)

Depreciation (buildings and care suites)(6,430) - (474)(6,904)

Depreciation and amortisation (chattels, leasehold

improvements and software)(2,508)-(914)(3,422)

(Loss) / Profit before income tax(26,532)34,346(27,323)(19,509)

Income tax benefit237(3,269)5,4772,445

(Loss) / Profit for the period attributable to shareholders(26,295)31,077(21,846)(17,064)

Other comprehensive income

Gain on revaluation of property, plant and equipment for the

period, net of tax30,137 - - 30,137

Loss on cash flow hedges, net of tax - - (1,231)(1,231)

Total comprehensive income /(loss) for the period

attributable to shareholders of the parent3,84231,077(23,077)11,842

1

Includes revenue of nil, operating expenses of $0.6m and EBITDA of ($0.6m) in relation to the Wesley Institute of Nursing Education.

2

Includes revenue of $5.3m, operating expenses of $1.6m and EBITDA of $3.7m in relation to the Wesley Institute of Nursing Education.

18

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

2.1 Operating Segments (continued)

Underlying net profit after tax (“Underlying Profit”)

Underlying Profit and Underlying EBITDA are non-GAAP measures of financial performance.

The calculation of Underlying Profit and Underlying EBITDA requires a number of estimates to be

approved by the Directors in their preparation. Both the methodology and the estimates may differ

among companies in the retirement village sector. Underlying Profit and Underlying EBITDA do not

represent cash flow generated during the period.

The Group calculates Underlying Profit and Underlying EBITDA by making the following

adjustments to reported Net Profit after Tax:

Total comprehensive income/ (loss) for the period

attributable to shareholders of the parent

RemoveFair value adjustments for investment property assets, property, plant and equipment, held for

sale assets and financial instruments

Add backImpairment of goodwill

Add back / removeLoss / gain on sale, decommissioning or purchase of assets and business assets including

associated costs and staff redundancy costs in the instance of a significant restructure or

change to the business model

Add backDepreciation (care suites)

RemoveInsurance income recognised in relation to material damage due to adverse weather events

Add backDirectors’ estimate of realised gains on the resale of units and care suites sold under an ORA

Add backDirectors’ estimate of realised development margin on the first sale of new ORA units or care

suites following the development of an ORA unit or care suite, conversion of an existing care bed

to a care suite or conversion of a rental unit to an ORA unit

Add backDeferred taxation component of taxation expense so that only the current tax expense is reflected

=Underlying Profit

RemoveInterest income

Add backFinance costs (including lease interest under NZ IFRS 16 Leases but excluding fair value of loan

modification and hedge ineffectiveness)

Add backDepreciation and amortisation (including right of use and property, plant and equipment)

Add backCurrent tax expense

=Underlying EBITDA

Resale gain – Underlying Profit

The Directors’ estimate of realised gains on resales of ORA units and care suites (i.e. the difference

between the incoming resident’s ORA licence payment and the ORA licence payment previously

received from the outgoing resident) is calculated as the net cash flow received, and receivable

at the point that the ORA contract becomes unconditional and has either “cooled off” (the

contractual period in which the resident can cancel the contract) or where the resident is in

occupation at balance date.

Development margin – Underlying Profit

The Directors’ estimate of realised development margin is calculated as the ORA licence payment

received, and receivable, in relation to the first sale of new ORA units and care suites, at the point

that the ORA contract becomes unconditional and has either “cooled off” or where the resident

is in occupation at balance date, less the development costs associated with developing the ORA

units and care suites. Where the development has been acquired in a business combination the

development costs are equal to the purchase price.

The Directors’ estimate of realised development margin for conversions is calculated based on the

difference between the ORA licence payment received, and receivable, in relation to sales of newly

converted ORA units and care suites, at the point that the ORA contract becomes unconditional

and has either “cooled off” or where the resident is in occupation at balance date, and the

associated conversion costs.

19

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

2.1 Operating Segments (continued)

The table below describes the composition of development and conversion costs.

IncludedNew builds:

• the construction costs directly attributable to the relevant project, including any required

infrastructure (e.g. roads) and amenities related to the units (e.g. landscaping) as well as any

demolition and site preparation costs associated with the project. The costs are apportioned

between the ORA units and care suites, in aggregate, using estimates provided by the project

quantity surveyor. The construction costs for the individual ORA units or care suites sold are

determined on a prorated basis using gross floor areas of the ORA units and care suites.

• an apportionment of land value based on the gross floor area of the ORA units and care suites

developed. The value for Brownfield

1

development land is the estimated fair value of land at the time

a change of use occurred

2

(from operating as a care centre or retirement village to a development

site), as assessed by an external independent valuer. Greenfield

3

development land is valued at

historical cost; and

• capitalised interest costs to the date of project completion apportioned using the gross floor area of

ORA units and care suites developed.

Conversions:

• of care beds to care suites - the actual refurbishment costs incurred; and

• of rental units to ORA units - the actual refurbishment costs incurred and the fair value of the rental

unit prior to conversion.

Excluded• Construction, land (apportioned on a gross floor area basis) and interest costs associated with

common areas and amenities or any operational or administrative areas.

1

Brownfield land refers to land previously utilised by, or part of, an operational aged care centre or retirement village.

2

The timing of a change of use is a Directors’ estimate. It is based on a range of factors including evidence of steps taken to secure a resource consent and/or

building consent for a particular development or stage of a development and the decommissioning of existing operations (either through the buy-back of existing

village ORA units or decommissioning of an existing care centre). Note the cost of buybacks is not included in the development cost as an independent fair value

of the land on an unencumbered basis is used as the value ascribed to the development land.

3

Greenfield land refers to land not previously utilised by, or as part of, an operational aged care centre or retirement village. Greenfield land is typically bare

(undeveloped) land at the time of purchase.

4

Includes revenue of nil, operating expenses of $0.3m and EBITDA of ($0.3m) in relation to the Wesley Institute of Nursing Education.

Six Months Ended 30 September 2025 (unaudited)

$NZ000’s

Care

Operations

Village

OperationsOtherTotal

Total comprehensive (loss) / income for the period

attributable to shareholders of the parent43,13629,030(31,773)40,393

Adjusted for Underlying Profit items

Less: Fair value adjustments for investment property assets,

property, plant and equipment, held for sale assets and

cashflow hedges(38,025)(22,903)395(60,533)

Add: Impairment of goodwill87 - - 87

Add: Depreciation (care suites)6,802 - - 6,802

Add: Amortisation of fair value of loan modification--716716

Add: Loss on sale of business assets including associated costs

and restructure costs4613621,0071,830

Add: Realised resale gain - 15,737 - 15,737

Add: Realised development margin - 22,670 - 22,670

Underlying net profit / (loss) before tax12,46144,896(29,655)27,702

Less: Deferred tax benefit (4,073)-154(3,919)

Underlying net profit / (loss) after tax8,38844,896(29,501)23,783

Less: Interest income - -(630)(630)

Add: Finance costs (excluding fair value of loan modification

and hedge ineffectiveness)--13,26313,263

Add: Depreciation (buildings)760-4771,237

Add: Depreciation and amortisation (chattels, leasehold

improvements and software)2,889 - 9673,856

Underlying EBITDA12,03744,896(15,424

4

)41,509

20

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

2.1 Operating Segments (continued)

Six Months Ended 30 September 2024 (unaudited)

$NZ000’s

Care

Operations

Village

OperationsOtherTotal

Total comprehensive income / (loss) for the period attributable

to shareholders of the parent3,84231,077(23,077)11,842

Adjusted for Underlying Profit items

Less: Fair value adjustments for investment property assets,

property, plant and equipment, held for sale assets and

cashflow hedges(4,172)(26,126)1,231(29,067)

Add: Impairment of goodwill198 - - 198

Add: Depreciation (care suites)5,674 - - 5,674

Add: Loss on sale of business assets including associated costs

and restructure costs - (398) - (398)

Add: Realised resale gain - 17,655 - 17,655

Add: Realised development margin - 20,519 - 20,519

Underlying net profit before tax5,54242,727(21,846)26,423

Less: Deferred tax benefit (237)3,269(5,477)(2,445)

Underlying net profit after tax5,30545,996(27,323)23,978

Less: Interest income - (326)(1,506)(1,832)

Add: Finance costs (excluding fair value of loan modification

and hedge ineffectiveness) 11,84811,848

Add: Depreciation (buildings)757 - 4741,231

Add: Depreciation and amortisation (chattels, leasehold

improvements and software)2,508 - 9143,422

Underlying EBITDA8,57045,670(15,593

1

)38,647

3. Property Assets

The Group operates care centres and retirement villages. As outlined in section 2.1, village sites are

typically investment property and care sites are typically property, plant and equipment.

What is Investment Property?

Land and buildings are classified as investment property when they are held to generate

revenue either through capital appreciation or through rental income.

As residents occupying our retirement villages live independently, the level of services provided

is seen as secondary to the provision of accommodation. Accordingly, these buildings are

classified as investment property as they are held primarily to generate DMF income.

What is Property, Plant and Equipment?

Land, buildings and chattels are classified as property, plant and equipment when

they are used to generate revenue through the provision of goods and services or for

administration purposes.

As residents occupying our care centres, including care suites, require services including

nursing care, meals and laundry the buildings in which they live are considered to be operated

by the Group to generate this revenue and are classified as property, plant and equipment.

What is a Care Suite?

Care suites are a premium offering for a resident requiring rest home or hospital level care. The

care suite is located within a care centre. Rather than pay a daily premium accommodation

charge for the provision of the premium room the residents enter into an ORA with a net

management fee.

What is Held for Sale?

Assets are classified as held for sale when the carrying amount will be recovered principally

through a sale transaction rather than through continuing use.

1

Includes revenue of $5.3m, operating expenses of $1.6m and EBITDA of $3.7m in relation to the Wesley Institute of Nursing Education.

21

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3. Property Assets (continued)

Classification of Serviced Apartments and Care Suites

Where services are provided to residents who occupy accommodation under an ORA, it is the

Group’s policy to assess their level of significance in the context of the overall income derived

from the serviced apartment or care suite in ascertaining whether the serviced apartment

or care suite is freehold land and buildings (referred to as property, plant and equipment) or

investment property.

The Group applies the following principles when ascertaining the appropriate accounting

treatment to be applied:

3.1 Village Assets: Investment Property

$NZ000’sNotes

Unaudited

September 25

Audited

March 25

Investment property under development at fair value

Opening balance139,865181,968

Impact of change to GST taxable supplies

2

(831)(593)

Capitalised expenditure (including land acquisitions)28,86154,575

Capitalised interest and line fees1,6988,806

Disposal-(305)

Transfer to completed investment property(660)(100,105)

Transfer to property, plant and equipment-(1,750)

Transfer from held for sale

3.3-1,340

Change in fair value during the period 65(4,071)

Closing balance168,998139,865

Completed investment property at fair value

Opening balance1,832,1681,633,418

Impact of change to GST taxable supplies

2

-(1,382)

Transfer from investment property under development660100,105

Transfer from/ (to) property, plant and equipment

3.2-(800)

Transfer from held for sale

3.3- 7,330

Capitalised expenditure9,66414,101

Capitalised interest and line fees-755

Disposal-(15,600)

Change in fair value during the period 22,83894,241

Closing balance1,865,3301,832,168

Total investment property2,034,3281,972,033

CLASSIFICATION

CONSIDERATION OF SIGNIFICANCE OF CASH FLOWS

SCENARIO

Additional services

are optional.

Services are

compulsory but an

insignificant portion

of total revenue

from the unit.

Services are

compulsory and a

significant portion

of the total revenue

from the unit.

Full ARRC

1


funded care is

compulsory

for that unit/bed.

Independent living

(villa or apartment)

Care suiteServiced apartmentTraditional care bedPrivate care

Qualitatively the

business model is

the provision of

retirement

accommodation.

Quantitatively

insignificant

(a guideline of

under 20% of total

revenue is adopted)

and qualitatively

the business model

is the provision

of retirement

accommodation.

Quantitatively

significant.

Qualitatively the

business model is

the provision of

care.

Qualitatively the

business model is

the provision of care.

Quantitative

assessment not

relevant as price

of accommodation

does not change

overall purpose of the

accommodation.

Investment Property

Village Assets

Property, Plant and

Equipment Care Assets

Operating

outside the ARRC

1


with services set

by the operator.

Qualitatively the

business model is

the provision of care.

Quantitative

assessment not

relevant as price

of accommodation

does not change

overall purpose of the

accommodation.

1

ARRC refers to age-related residential care.

2

Relates to GST claimed on land purchased in a prior period subject to a change in use adjustment in the current period.

22

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3.1 Village Assets: Investment Property (continued)

Change in Fair Value Recognised in the Consolidated Statement of Comprehensive Income

$NZ000’s

Unaudited

September 25

Unaudited

September 24

Increase in fair value of investment property62,29580,648

Less: Transfers to property, plant and equipment, right of use assets and held for sale during

the period- (6,920)

Less: Capitalised expenditure including capitalised interest(39,392)(47,588)

Change in fair value recognised in Consolidated Statement of Comprehensive Income22,90326,140

A reconciliation between the valuation and the amount recognised as investment property is

as follows:

$NZ000’s

Unaudited

September 25

Audited

March 25

Investment Property under development

Valuation168,998139,865

168,998139,865

Completed Investment Property

Valuation901,768919,089

Add: Refundable occupation licence payments1,174,1871,121,025

Add: Residents’ share of resale gains5,0005,050

Less: Management fee receivable(203,390)(190,387)

Less: Resident obligations for units not included in valuation (12,235)(22,609)

1,865,3301,832,168

Total investment property at fair value2,034,3281,972,033

Where an incoming resident has an unconditional ORA in respect of a retirement village unit and

the corresponding outgoing resident for that same accommodation has not yet been refunded,

the independent valuation is adjusted for the incoming resident balances only. In certain

circumstances accommodation under an ORA is valued as development land. In these situations

the independent valuation is not adjusted for the refundable amounts and consequently no

offsetting “gross up” is required. An adjustment of $12.2m (March 2025: $22.6m) is included in

the above reconciliation to reflect this.

The valuation of investment property is adjusted for cash flows relating to refundable occupation

licence payments, residents’ share of resale gains and management fee receivable recognised

separately on the Consolidated Balance Sheet and also reflected in the valuation model.

Why do we adjust for the liability to residents?

In the external valuation the fair value of investment property includes an allowance for the

amount that is payable by the Group to residents already in occupation within the property.

However, this liability to existing residents is recognised in the Group’s Consolidated Balance

Sheet (referred to as refundable occupation right agreements – refer to note 3.4). Accordingly,

the Group adds this net liability to residents to the external valuation to “gross up” the fair

value of investment property and avoid double counting the liability to residents.

Valuation Process and Key Inputs

Investment Property under Development

CBRE Limited provided a desktop review of development land in respect of investment property

under development as at 30 September 2025 (March 2025: CBRE Limited full valuation).

The fair value of investment property is determined by the Directors having taken into consideration

the valuation conducted by the external valuers as independent registered valuers and the cost of

work undertaken in relation to investment property under development, including any associated

capitalised interest costs during the development period.

The Group has applied the following methodology in relation to the measurement of investment

property under development:

Practical completion not achieved

Where the development still requires substantial work such that practical completion is not going

to be achieved, and a reliable estimate of fair value cannot be made, at or close to balance date,

the fair value recognised is the fair value of the development land per the Directors’ valuation

plus the cost of any work in progress. Work in progress includes any interest costs on debt

drawn to fund the development during the development period. A work in progress amount of

$5.3m as at 30 September 2025 (March 2025: $40.9m) has been recognised in relation to these

development sites.

Where an individual development is of both investment property and freehold buildings in nature,

the fair value of land and work in progress is apportioned between investment property under

development and freehold land and buildings under development, by applying the estimated gross

floor area for these respective areas of the development based on information obtained from the

project quantity surveyors at the planning and design stages.

23

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3.1 Village Assets: Investment Property (continued)

Practical completion achieved

Where a development is practically completed, or likely to be completed at, or close to, balance

date the investment property is measured at its completed fair value per the Directors’ valuation

with an adjustment made for any estimated costs, in accordance with the project budget, to be

incurred to complete the development, and is then transferred to completed investment property.

Completed Investment Property

CBRE Limited provided a desktop review of investment property as at 30 September 2025

(31 March 2025: CBRE Limited full valuation).

As required by NZ IAS 40 Investment Property, the valuation of investment property is adjusted for

cash flows relating to refundable occupation licence payments, residents’ share of resale gains and

management fees receivable recognised separately on the Consolidated Balance Sheet and also

reflected in the valuation model.

Any interest costs incurred on outstanding development debt balances after the completion of

the development are recognised through the Statement of Comprehensive Income, an amount of

$3.8m in the period (September 2024: $3.0m).

The Group’s interest in all completed investment property was valued on 30 September 2025 by

CBRE Limited (March 2025: CBRE Limited) at a total of $901.8m (March 2025: $919.1m).

Property Specific Assumptions

Seismic Assessments

In the prior period the external valuations, and accordingly the fair value of investment property,

incorporated an allowance in relation to remediation to properties where seismic strength testing

has been carried out.

Significant Unobservable Inputs

The significant unobservable input used in the fair value measurement of the Group’s development

land is the value per m2 assumption. Increases in the value per m2 rate result in the corresponding

increases in the total valuation.

The significant unobservable inputs used in the fair value measurement of the Group’s portfolio of

completed investment property are the discount rate and property price growth rate. There are no

interdependencies or interplays between unobservable inputs.

3.2 Care Assets: Property, Plant and Equipment


$NZ000’sNotes

Freehold Land

and Buildings

Under

Development

Freehold

Land

Freehold

Buildings

Chattels and

Leasehold

ImprovementsTotal

Period ended 30 September 2025

(unaudited)

Opening net book amount49,591125,202624,52129,172828,486

Additions2,261 - 3,6563,1069,023

Capitalised interest and line fees146 - 485 - 631

Disposals(61)(421)(1,159)(233)(1,874)

Depreciation

1

- - (7,510)(2,807)(10,317)

Transfer from investment property

3.1- - - - -

Reclassification within Property, Plant and

Equipment(40,492)4,35434,6341,504 -

Revaluation surplus

Change in fair value recognised in

comprehensive income -1252,054 - 2,179

Change in fair value recognised in other

comprehensive income

2

5,77439133,754 - 39,919

Closing net book amount 17,219129,651690,43530,742868,047


At 30 September 2025

Cost -- - 68,11268,112

Valuation 17,219129,651690,435 - 837,305

Accumulated depreciation - - - (37,370)(37,370)

Net book amount17,219129,651690,43530,742868,047

1

The amounts on the face of the Statement of Comprehensive Income in relation to depreciation includes $1.6m in relation to right of use assets and software

amortisation not included in this note.

2

The revaluation noted in the Statement of Comprehensive Income differs from the above due to deferred tax.

24

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3.2 Care Assets: Property, Plant and Equipment (continued)

$NZ000’sNotes

Freehold Land

and Buildings

Under

Development

Freehold

Land

Freehold

Buildings

Chattels and

Leasehold

ImprovementsTotal

Year ended 31 March 2025 (audited)

Opening net book amount78,608116,111554,70321,455770,877

Additions21,357-8,8479,28439,488

Capitalised interest and line fees1,438-1,960-3,398

Disposals-----

Depreciation

1

--(13,358)(5,660)(19,018)

Transfer from investment property

3.11,750- 800-2,550

Transfer to held for sale

3.3482,8002,7975526,197

Reclassification within Property, Plant and

Equipment(42,825)1,78237,5023,541-

Revaluation surplus

Change in fair value recognised in

comprehensive income

2

(9,685)(245)(16,081)-(26,011)

Change in fair value recognised in other

comprehensive income

3

(1,100)4,75447,351-51,005

Closing net book amount 49,591125,202624,52129,172828,486

At 31 March 2025

Cost ---64,14264,142

Valuation 49,591125,202624,521-799,314

Accumulated depreciation ---(34,970)(34,970)

Net book amount49,591125,202624,52129,172828,486

Land and Buildings Under Development

A desktop review in respect of development land was provided by CBRE Limited as at

30 September 2025 (March 2025: full valuation).

Any costs incurred to 30 September 2025 on the developments are included in arriving at the

fair value as at 30 September 2025.

The Group has applied the following methodology in relation to the measurement of land and

buildings under development:

Practical completion not achieved

Where the development still requires substantial work such that practical completion is not going

to be achieved, and a reliable estimate of fair value cannot be made, at or close to balance date,

the fair value recognised is the fair value of the development land per the Directors’ valuation

plus the cost of any work in progress. Work in progress includes any interest costs on debt

drawn to fund the development during the development period. A work in progress amount of

$5.3m as at 30 September 2025 (March 2025: $30.6m) has been recognised in relation to these

development sites.

Where an individual development is of both investment property and freehold buildings in nature,

the fair value of land and work in progress is apportioned between investment property under

development and freehold land and buildings under development, by applying the estimated gross

floor area for these respective areas of the development based on information obtained from the

project quantity surveyors at the planning and design stages.

Practical completion achieved

Where a development is practically completed, or likely to be completed at, or close to, balance

date the land and buildings are measured at its completed fair value per the Directors’ valuation

with an adjustment made for any estimated costs, in accordance with the project budget, to be

incurred to complete the development, and is then transferred to completed land and buildings.

1

The amounts on the face of the Statement of Comprehensive Income in relation to depreciation includes $3.1m in relation to right of use assets and software

amortisation not included in this note.

2

One site, Elmwood, has just completed a brownfield care development. This development required the closure of the existing care suites and a number of

residents were relocated to the newly developed care suite building. Impairments of $25.8m and $2.4m were recognised in Comprehensive Income and Other

Comprehensive Income within the Consolidated Financial Statements for the year ended 31 March 2025.

3

The revaluation noted in the Statement of Comprehensive Income differs from the above due to deferred tax.

25

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3.2 Care Assets: Property, Plant and Equipment (continued)

Completed Land and Buildings

A desktop review in respect of completed land and buildings was provided by CBRE Limited as at

30 September 2025 (March 2025: full valuation).

Any interest costs incurred outstanding development debt balances after the completion of that

development are recognised through the Statement of Comprehensive Income, an amount of

$2.0m in the period (September 2024: $1.4m).

The valuation of the Group’s care centres was apportioned to land, buildings, chattels and

goodwill. The fair value of land and buildings as calculated by CBRE Limited is based on the level

of rent able to be generated from the maintainable net cash flow of the site subject to average

efficient management. The fair value of the Group’s land and buildings as determined by the

Directors is based on these apportionments. However, chattels are carried at historic cost less

depreciation and the amount apportioned to goodwill by CBRE Limited is not recorded in the

consolidated financial statements.

Care Suites and Serviced Apartments

As discussed earlier in note 3, where services are provided to residents who occupy

accommodation under an ORA, it is the Group’s policy to look at the significance of these

services in the context of the overall revenue derived from the care suite or serviced apartment

in ascertaining whether the care suite or serviced apartment is property, plant and equipment

or investment property. Care suite residents occupying accommodation under an ORA receive a

significant level of services. Hence, they are included in property, plant and equipment. Care suite

land and buildings are held at fair value.

Serviced apartments relate to accommodations where a base level of services are provided to

independent residents and are classified as investment property.

Key Accounting Estimates and Judgements

All land and buildings have been determined to be Level 3 (March 2025: Level 3) in the fair value

hierarchy as the fair value is determined using inputs that are unobservable.

Significant Unobservable Inputs

The significant unobservable input used in the fair value measurement of the Group’s development

land is the value per m2 assumption. Increases in the value per m2 rate result in the corresponding

increases in the total valuation.

The significant unobservable inputs used in the fair value measurement of the Group’s portfolio

of completed land and buildings is the capitalisation rate applied to earnings. A significant

decrease/ (increase) in the capitalisation rate would result in significantly higher/ (lower) fair

value measurement.

3.3 Held for Sale

Assets are classified as held for sale when their carrying amount is to be recovered principally

through a sale transactions and a sale is considered highly probable. They are stated at the lower

of carrying amount and fair value less costs to sell, except for investment property assets held for

sale which are carried at fair value.

Assets previously classed as Investment Properties are held on the Consolidated Balance Sheet

at their fair value, assets previously classed as Property, Plant and Equipment are held on the

Consolidated Balance Sheet at current valuation, which is the lower of fair value less costs to sell

and the carrying amount.

Changes in fair value from the date of classification to held for sale are recognised in

comprehensive income. See note 3.4 for resident liabilities associated with held for sale assets in

the prior period.

As at 30 September 2025 there are no sites that meet the accounting definition of held for sale.

Sites currently being considered for divestment are subject to targeted negotiations or have

previously been classified as Held for Sale for more than 12 months. (March 2025: nil).

26

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

3.4 Refundable Occupation Right Agreements

What is an ORA?

An ORA is a contract which sets out the terms and conditions of occupation of an independent

living unit or care suite. A new resident is charged a refundable occupation licence payment in

consideration for the right to occupy one of the Group’s units, apartments or care suites. On

termination of the ORA the occupation licence payment is repaid to the exiting resident.

What is DMF?

An amount equal to a capped percentage of the occupation licence payment is charged by

the Group as a management fee for the right of use of the unit and enjoyment of the common

areas of the village. The deferred management fee is payable by the resident on termination

of the ORA.

$NZ000’s

Unaudited

September 25

Audited

March 25

Village

Refundable occupation licence payments1,174,1871,121,025

Residents’ share of resale gains5,0005,050

Less: Management fee receivable (per contract)(253,739)(241,897)

925,448884,178


Care Suites

Refundable occupation licence payments300,458273,778

Less: Management fee receivable (per contract)(54,740)(51,143)

245,718222,635

Total refundable occupation right agreements1,171,1661,106,813

Reconciliation of Management Fees recognised under NZ IFRS and per ORA

$NZ000’s

Unaudited

September 25

Audited

March 25

Village

Management fee receivable (per contract)(253,739)(241,897)

Deferred management fee50,34951,510

Management fee receivable (per NZ IFRS)(203,390)(190,387)

Care Suites

Management fee receivable (per contract)(54,740)(51,143)

Deferred management fee5,0145,769

Management fee receivable (per NZ IFRS)(49,726)(45,374)

4. Shareholder Equity and Funding

4.1 Shareholder Equity and Reserves

Unaudited

September

2025

Shares

Audited

March 2025

Shares

Unaudited

September

2025

$NZ000’s

Audited

March 2025

$NZ000’s

Share capital

Issued and fully paid-up capital724,231,030724,231,030715,960715,960

Total contributed equity724,231,030724,231,030715,960715,960

Movements

Opening balance of ordinary shares issued724,231,030724,154,779715,960715,960

Shares issued for Long Term Incentive Scheme-76,251--

Closing balance of ordinary shares issued724,231,030724,231,030715,960715,960

All ordinary shares rank equally with one vote attached to each fully paid ordinary share. The

shares have no par value. The Company incurred no transaction costs issuing shares during the

period (March 2025: nil).

27

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

4.1 Shareholder Equity and Reserves (continued)

Long Term Incentive (“LTI”)

On 15 September 2020 the Board approved a Long Term Incentive Scheme for its senior executives

(“LTI Scheme”). The LTI Scheme was established to:

a. provide an incentive to key executives to commit to Oceania for the long term; and

b. align these executives’ interests with the interests of Oceania’s shareholders.

Participants in the Scheme were granted Share Rights from time to time which, subject to meeting

certain performance hurdles and the vesting criteria, convert into an entitlement to receive

ordinary shares. The performance hurdles relate to Oceania’s total shareholder return relative to

the NZX50 Group and, for certain schemes, Oceania’s performance against underlying earnings

per share targets.

Share Rights became exercisable if the performance hurdles were met over the period from the

commencement date to the measurement date and the holder remained employed on the vesting

date, and in certain other exceptional circumstances. On becoming exercisable, each Share Right

entitled the holder to receive one fully paid ordinary share in Oceania Healthcare Limited, less an

adjustment for tax paid on the holder’s behalf for the benefit received under the Scheme. The Share

Rights had a nil exercise price.

Share Rights lapse where the performance hurdles are not met on a relevant measurement date

or, in general, where the participant ceases to be employed by the Group before the vesting date

(except in exceptional circumstances).

SchemeIssue DateShare Rights issuedShare Rights lapsedShare Rights vested

2020 LTI20 September 20201,948,0611,599,054349,007

2021 LTI10 September 20211,078,125984,87593,250

2022 LTI18 November 20221,430,1501,430,150-

LTI – Share Options

On 11 September 2023 the Board approved a new Share Option Plan. The option plan was

established to:

(a) Reward and retain key employees;

(b) Drive longer-term performance and alignment of incentives of participants with the interests

of Oceania’s shareholders; and

(c) Encourage longer term decision-making by participants.

Participants in the Option Plan are granted options to acquire ordinary shares from time to time.

These options are exercisable by participants subject to those participants’ continued employment

by Oceania, during specified exercise periods for a set exercise price. On exercise of the options,

the Group will facilitate a cashless (net settled) exercise by issuing such number of shares as

is equal to the difference between the then current market value of Oceania’s shares and the

exercise price (less an adjustment for tax paid on the holder’s behalf for the benefit received),

multiplied by the number of options being exercised, divided by the then current market value

of Oceania’s shares.

28

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

4.1 Shareholder Equity and Reserves (continued)

SchemeIssue DateExercise Date

Participants as

at 30 Sept 2025

Share Options

issued

Share Options

forfeited

Exercise

price

2023 Option Plan11 September 2023May 2026316,666,6677,142,858$0.82

2023 Option Plan30 April 2024May 202604,761,9044,761,904$0.82

2023 Option Plan15 October 2024May 202675,476,1951,428,573$0.82

2024 Option Plan15 October 2024May 20271775,385n/a$0.76

2024 Option Plan10 December 2024May 20272938,461307,692$0.76

2025 Option Plan23 June 2025May 202823,059,190n/a$0.65

2025 Option Plan5 September 2025May 20281660,000n/a$0.65

Dividends

Unaudited

September

2025

cents

per share

Unaudited

September

2025

$NZ000’s

Audited

March 2025

cents

per share

Audited

March 2025

$NZ000’s

Final dividend for the prior period ----

Interim dividend for the period ----

Total dividends declared during the period---

Oceania has updated its dividend policy to better align dividend payments with operating

cashflows. The dividend policy is to pay out between 40% and 60% of Free Cash Flow from

Operations. The Board may consider a dividend above or below this policy range, subject to the

Company’s cash flow requirements and investment opportunities.

Free Cash Flow from Operations adjusts statutory operating cash flows by excluding development

related sales and buybacks, and incorporating maintenance capital expenditure, lease principal

repayments, and other one off items outside the normal course of business.

Asset Revaluation Reserve

The asset revaluation reserve is used to record the revaluation of freehold land and buildings and

land and buildings under development. The amounts are recognised in the Consolidated Statement

of Comprehensive Income when it affects profit or loss. Refer to note 3.2.

Cash Flow Hedge Reserve

The cash flow hedge reserve is used to record gains or losses on instruments used as cash flow

hedges. The amounts are recognised in the Consolidated Statement of Comprehensive Income

when the hedged transaction affects profit or loss. Refer to note 5.6 of the 31 March 2025

consolidated financial statements.

4.2 Earnings per share

Basic

Basic earnings per share is calculated by dividing the profit after tax of the Group by the weighted

average number of ordinary shares outstanding during the period.

Unaudited

September

2025

Unaudited

September

2024

Profit/ (Loss) after tax ($’000)4,942(17,064)

Weighted average number of ordinary shares outstanding (‘000s)724,231724,204

Basic earnings per share (cents per share)0.7(2.4)

Diluted

Diluted earnings per share is calculated by adjusting the weighted average number of ordinary

shares outstanding to assume conversion of all dilutive potential ordinary shares. As at

30 September 2025 there were nil shares with a dilutive effect (September 2024: Nil).

Unaudited

September

2025

Unaudited

September

2024

Profit/ (Loss) after tax ($’000)4,942(17,064)

Weighted average number of ordinary shares outstanding (‘000s)724,231724,204

Diluted earnings per share (cents per share)0.7(2.4)

29

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

4.3 Borrowings

$NZ000’s

Unaudited

September

2025

Audited

March 2025

Secured

Bank loans392,568410,633

Capitalised loan costs(1,606)(1,028)

Loan Modification gain(4,708)(5,425)

Retail Bond – OCA010125,000125,000

Retail Bond – OCA020100,000100,000

Capitalised bond costs(1,181)(1,432)

Total borrowings610,073627,748

Current--

Non current617,568635,633

Total borrowings excluding capitalised loan costs and loan modification gains617,568635,633

Recognition and Measurement

Bank Loans

Interest is charged using the BKBM Bill rate plus a margin and line fee. Interest rates applicable

in the six month period to 30 September 2025 ranged from 4.0% to 5.2% (year to 31 March 2025:

5.0% to 7.1%).

Retail Bond

NZDX IDIssue DateNo. of bonds$NZ000’sMaturityFixed Interest

Unaudited

Trading Interest

at September 25

Audited

Trading Interest

at March 25

OCAO1019 Oct 20125.0m$125,00019 Oct 272.3%5.8%6.81%

OCA02013 Sept 21 100.0m$100,00013 Sept 283.3%5.27%6.15%

The bonds are quoted on the NZX Debt Market and their fair value at balance date is based on

their listed market price as at balance date. Interest on OCA010 is payable quarterly in January,

April, July and October in equal instalments. As at 30 September 2025 the fair value of OCA010

was $116.7m (31 March 2025: $112.8m).

Interest on OCA020 is payable quarterly in March, June, September and December

in equal instalments. As at 30 September 2025 the fair value of OCA020 was $93.8m

(31 March 2025: $90.9m).

Debt Financing

On 4 March 2025 it was announced that the group has extended the maturity of it bank debt

facilities to three and five years and introduced a new lender to the syndicate with financial

close to occur on 1 May 2025. The total limit of bank facilities will remain at $500m and the

split as follows:

i. General Corporate Facility limit $50m, 3 year tenor;

ii. General Corporate Facility limit $185m, 5 year tenor; and

iii. Development Facility limit remains at $265m, 5 year tenor.

The facilities are held by a banking syndicate comprising ANZ, BNZ, ASB and ICBC.

The refinance included a change to interest rates which has resulted in the recognition of a loan

modification gain of $5.4m as at 31 March 2025.

On 1 May 2025, concurrent with financial close, the group reallocated $50m from the five year

General Corporate Facility to the Development Facility.

The entire debt facility is sustainability-linked for the entire five year period with a penalty in the

event of the Group not satisfying certain ESG targets and an interest discount in the event that

certain targets are met. For the period to 31 March 2025, two targets were met and a discount

was received.

Financing Arrangements

At 30 September 2025, the Group held committed bank facilities with drawings as follows:

$NZ000’s

Unaudited

September 2025

Audited

March 2025

CommittedDrawnCommittedDrawn

General Corporate Facility185,000105,005185,000112,105

Development Facility315,000287,563315,000298,528

Total500,000392,568500,000410,633

The Group’s revolving Development Facility is utilised to cover costs associated with current

development projects. The revolving General Corporate Facility is used for general corporate

purposes as well as for development land and initial costs for projects not currently funded by

the Development Facility.

30

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

4.3 Borrowings (continued)

Interest on the General Corporate Facility is typically payable quarterly. Interest on the

Development Facility is capitalised and repaid together with principal using the ORA licence

proceeds received upon settlement of initial sales of newly developed units and care suites. Line

fees are payable quarterly on the committed General Corporate Facility and the Committed

Development Facility.

The financial covenants in the Group’s debt facilities, with which the Group must comply include:

a) Interest Cover Ratio - the ratio of Adjusted EBITDA to Net Interest Charges, where interest

charges relates to the interest and commitment fees in relation to the General Corporate

Facility, is not less than 2.0x;

b) Loan to Value Ratio – the ratio of total bank indebtedness shall not exceed 50% of the total

property value of all Group’s properties (including the “as-complete” valuations for projects

funded under the Development Facility); and

c) Guarantor Group Coverage – at all times the adjusted EBITDA of the Guaranteeing Group

must be at least 90% of the Adjusted EBITDA of the total tangible assets of the Group; and

d) Development – at all times the outstanding principal amount under the Development

Facility shall not exceed the Development Value. Development Value (per the most recent

valuation excluding any settled stock) is the aggregate value of all Residential Facilities in all

Developments that are being funded by the Development Facility less their cost to complete.

The covenants are tested half yearly. All covenants have been complied with during the period. The

Group has agreed with its banks that the calculation of Adjusted EBITDA and Net Interest, for the

purposes of the financial covenants, shall continue to be based on the accounting treatment in use

before the introduction of NZ IFRS 16 Leases. No changes have been made to these covenants as

part of the refinance.

Assets Pledged as Security

The bank loans and bonds of the Group are secured by mortgages over the Group’s care centre

freehold land and buildings and rank second behind the Statutory Supervisors where the land and

buildings are classified as investment property and investment property under development.

As at 30 September 2025 the balance of the bank loans over which the properties are held as

security is $392.6m (March 2025: $410.6m).

5. Other Disclosures

5.1 Trade and Other Receivables

$NZ000’s

Unaudited

September 25

Audited

March 25

Net trade and other receivables

Trade receivables20,93619,207

Less: Loss allowance (277)(263)

20,65918,944

Occupation licence payment receivable

1

88,80893,895

Insurance Receivables-248

Prepayments and Other Receivables3,7844,704

Trade and other receivables113,251117,791

Recognition, Measurement and Judgements in Applying Accounting Policies

The Group applies the simplified approach to measuring expected credit losses which uses a

lifetime expected loss allowance for all trade receivables and requires recognition from initial

recognition of the trade receivable. To measure expected credit losses, trade receivables have been

grouped and reviewed on the basis of the number of days since resident departure and the funding

stream and type of debtor. Judgement is used in selecting the inputs to the impairment calculation

and is based on past history and forward looking assumptions.

The Group has the following financial assets subject to the application of the expected credit

loss model:

• Trade receivables from care operations for the provision of care fees revenue for rest home and

hospital fees. These are split between private amounts owed by residents and amounts due from

agencies such as the Ministry of Health and ACC.

• Trade receivables from village operations for the provision of weekly service fees and occupation

licence payment receivables. These are receivable from residents.

The Group has applied a simplified approach to calculating the expected loss rate expected by applying

a 1.5% allowance to trade receivables from care operations (March 2025: 1.5%) and 0% from village

operations (March 2025: 0%), adjusted for any other known factors with respect to individual debts.

There is no significant concentration of credit risk as trade receivables relate to individual residents

and government agencies.

1

Occupation licence receivable includes an amount of $65.0m in relation to short term occupation licence receivables expected to be recovered in less than

12 months. (March 2025: $65.1m).

31

Oceania

Interim Report 2026

Notes to the Consolidated financial statements
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

5.2 Contingencies and Commitments

At 30 September 2025, the Group had no contingent liabilities (March 2025: nil).

At 30 September 2025, the Group has a number of commitments to develop and construct certain

development sites totalling $11.5m (March 2025: $31.0m).

On 15 September 2025, the Group entered into a conditional sale and purchase agreement for a

3.7-hectare parcel of land adjacent to Franklin Village. The purchase is conditional on procuring

rezoning of the property and obtaining a resource consent from the relevant authority that permits

the Group’s intended use and development. A non refundable deposit of $0.3 million was paid

on 29 October 2025. The balance of the purchase price becomes due once all conditions have

been met and will be paid in staged instalments, with all payments expected to be completed

by March 2030.

There are no significant unrecognised contractual obligations entered into for future repairs

and maintenance at balance date.

5.3 Events After Balance Date

There have been no significant events after balance date.

32

Oceania

Interim Report 2026

Independent Auditor’s Review Report
A member firm of Ernst & Young Global Limited

IInnddeeppeennddeenntt aauuddiittoorr’’ss rreevviieeww rreeppoorrtt ttoo tthhee sshhaarreehhoollddeerrss ooff

OOcceeaanniiaa HHeeaalltthhccaarree LLiimmiitteedd

CCoonncclluussiioonn

We have reviewed theconsolidated interimcondensedfinancial statements ("interim financial statements") ofOceania

Healthcare Limited (“the Company”)and its subsidiaries (together “the Group”)on pages 11to 32which comprise the

consolidatedbalance sheetas at 30 September 2025, and the consolidatedstatement of comprehensive income,

consolidatedstatement of changes in equity and consolidatedcash flow statementfor the six monthsended on that date, and

explanatory notes. Based on our review, nothing has come to our attention that causes us to believe that the accompanying

interimfinancial statements on pages 11to 32of the Groupdo not present fairly, in all material respects,the financial position

oftheGroupas at 30 September 2025, and its financial performance and its cash flows for the six monthsended on that date,

in accordance with New Zealand Equivalent to International Accounting Standard 34:

Interim Financial Reporting(NZ IAS 34)

andInternational Accounting Standard 34:

Interim Financial Reporting(IAS 34).

This report is made solely to the Company’s shareholders, as a body. Our review has been undertaken so that we might state to

the Company’s shareholders those matters we are required to state to them in a review report and for no other purpose. To the

fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the

Company’s shareholders as a body, for our review procedures, for this report, or for the conclusion we have formed.

BBaassiiss ffoorr ccoonncclluussiioonn

We conducted our review in accordance with NZSRE2410 (Revised) Review of Financial Statements Performed by the

Independent Auditor of the Entity

. Our responsibilities are further described in the Auditor’s responsibilities for the review of the

financial statements

section of our report. We are independent of the Groupin accordance with the relevant ethical

requirements in New Zealand relating to the audit of the annual financial statements, and we have fulfilled our other ethical

responsibilities in accordance with these ethical requirements.

Ernst & Young provides sustainability assuranceservicesand statutory supervisor reportingservicestothe Group. Partners and

employees of our firm may deal with the Groupon normal terms within the ordinary course of trading activities of the business of

the Group. We have no other relationship with, or interest in, the Group.

DDiirreeccttoorrss’’ rreessppoonnssiibbiilliittyy ffoorr tthhee iinntteerriimm ffiinnaanncciiaall ssttaatteemmeennttss

The directorsare responsible, on behalf of the Entity, for the preparation and fair presentationof the interimfinancial

statements in accordance with NZ IAS 34and IAS 34and for such internal control as the directorsdetermine is necessary to

enable the preparation and fair presentationof the interimfinancial statements that are free from material misstatement,

whether due to fraud or error.

AAuuddiittoorr’’ss rreessppoonnssiibbiilliittiieess ffoorr tthhee rreevviieeww ooff tthhee iinntteerriimm ffiinnaanncciiaall ssttaatteemmeennttss

Our responsibility is to express a conclusion on the interimfinancial statements based on our review. NZSRE2410 (Revised)

requires us to conclude whether anything has come to our attention that causes us to believe that the interimfinancial

statements, taken as a whole, are not prepared in all material respects, in accordance with NZ IAS 34 and IAS 34.

A member firm of Ernst & Young Global Limited

IInnddeeppeennddeenntt aauuddiittoorr’’ss rreevviieeww rreeppoorrtt ttoo tthhee sshhaarreehhoollddeerrss ooff

OOcceeaanniiaa HHeeaalltthhccaarree LLiimmiitteedd

CCoonncclluussiioonn

We have reviewed theconsolidated interimcondensedfinancial statements ("interim financial statements") ofOceania

Healthcare Limited (“the Company”)and its subsidiaries (together “the Group”)on pages 11to 32which comprise the

consolidatedbalance sheetas at 30 September 2025, and the consolidatedstatement of comprehensive income,

consolidatedstatement of changes in equity and consolidatedcash flow statementfor the six monthsended on that date, and

explanatory notes. Based on our review, nothing has come to our attention that causes us to believe that the accompanying

interimfinancial statements on pages 11to 32of the Groupdo not present fairly, in all material respects,the financial position

oftheGroupas at 30 September 2025, and its financial performance and its cash flows for the six monthsended on that date,

in accordance with New Zealand Equivalent to International Accounting Standard 34:

Interim Financial Reporting(NZ IAS 34)

andInternational Accounting Standard 34:

Interim Financial Reporting(IAS 34).

This report is made solely to the Company’s shareholders, as a body. Our review has been undertaken so that we might state to

the Company’s shareholders those matters we are required to state to them in a review report and for no other purpose. To the

fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the

Company’s shareholders as a body, for our review procedures, for this report, or for the conclusion we have formed.

BBaassiiss ffoorr ccoonncclluussiioonn

We conducted our review in accordance with NZSRE2410 (Revised) Review of Financial Statements Performed by the

Independent Auditor of the Entity

. Our responsibilities are further described in the Auditor’s responsibilities for the review of the

financial statements

section of our report. We are independent of the Groupin accordance with the relevant ethical

requirements in New Zealand relating to the audit of the annual financial statements, and we have fulfilled our other ethical

responsibilities in accordance with these ethical requirements.

Ernst & Young provides sustainability assuranceservicesand statutory supervisor reportingservicestothe Group. Partners and

employees of our firm may deal with the Groupon normal terms within the ordinary course of trading activities of the business of

the Group. We have no other relationship with, or interest in, the Group.

DDiirreeccttoorrss’’ rreessppoonnssiibbiilliittyy ffoorr tthhee iinntteerriimm ffiinnaanncciiaall ssttaatteemmeennttss

The directorsare responsible, on behalf of the Entity, for the preparation and fair presentationof the interimfinancial

statements in accordance with NZ IAS 34and IAS 34and for such internal control as the directorsdetermine is necessary to

enable the preparation and fair presentationof the interimfinancial statements that are free from material misstatement,

whether due to fraud or error.

AAuuddiittoorr’’ss rreessppoonnssiibbiilliittiieess ffoorr tthhee rreevviieeww ooff tthhee iinntteerriimm ffiinnaanncciiaall ssttaatteemmeennttss

Our responsibility is to express a conclusion on the interimfinancial statements based on our review. NZSRE2410 (Revised)

requires us to conclude whether anything has come to our attention that causes us to believe that the interimfinancial

statements, taken as a whole, are not prepared in all material respects, in accordance with NZ IAS 34 and IAS 34.

A member firm of Ernst & Young Global Limited

A review of interimfinancial statements in accordance with NZSRE2410 (Revised) is a limited assurance engagement. We

perform procedures, consisting of making enquiries, primarily of persons responsible for financial and accounting matters, and

applying analytical and other review procedures. The procedures performed ina review are substantially less than those

performed in an audit conducted in accordance with International Standards on Auditing (New Zealand) and consequently do

not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit.

Accordingly, we do not express an audit opinion on those interimfinancial statements.

The engagement partner on the review resulting in this independent auditor’s review report is Brent Penrose.

[Sign Ernst & Young]

Chartered Accountants

Auckland

21 November 2025

A member firm of Ernst & Young Global Limited

A review of interimfinancial statements in accordance with NZSRE2410 (Revised) is a limited assurance engagement. We

perform procedures, consisting of making enquiries, primarily of persons responsible for financial and accounting matters, and

applying analytical and other review procedures. The procedures performed ina review are substantially less than those

performed in an audit conducted in accordance with International Standards on Auditing (New Zealand) and consequently do

not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit.

Accordingly, we do not express an audit opinion on those interimfinancial statements.

The engagement partner on the review resulting in this independent auditor’s review report is Brent Penrose.

[Sign Ernst & Young]

Chartered Accountants

Auckland

21 November 2025

33

Oceania

Interim Report 2026

oceaniahealthcare.co.nz

---

21 November 2025
Interim Results

1HY26

Agenda
Topic

Current Focus2

Overview3

Sales Performance5

Business Excellence13

Capital Management17

Financials22

Looking Forward26

Appendices30

2
Current Focus (FY26 -FY27 Priorities)

1. Sales Performance2. Business Excellence

3. Capital Management

Building a disciplined sales and

marketing function to accelerate

applications and occupancy

Embedding optimisationinitiatives

across the business to lift performance

Optimisingcapital structure to

deliver stronger, more sustainable

growth for shareholders

This work is already delivering near term gains while positioning us for sustainable, long termvalue creation.

Our priority is to lay the strongest possible foundation for strategy execution

3
1. Sales Performance

Strong sales volumes:

5% increase on 1HY25

The Helier:

54.5% occupied

1


as at20 November 2025

Strong presales at Franklin:

35.5% presold to date

2. Business Excellence

Cost savings realised:

$4.0mrealisedduring 1HY26,

$13.2mon track to be realisedduring

FY26

Strong occupancy:

Occupancy increased to 94.7%

2

from

94.0% in 1HY25

Care profitability uplift:

Care EBITDA per bed

3

has climbed

45.5% to $12.4k, reflecting stronger

operational performance across the

portfolio

3. Capital Management

Gearing reduced:

34.8% gearing within target range of

30 – 35%

Divestments actively progressing:

the divestment of four sites, targeted

for completion in FY26

Overview

1.Occupied refers to sold under ORA, occupied under Respite, occupied under PAC and under application

2.Occupancy not affected by development. Care occupancy for the entire portfolio increased to 91.9% from 91.6% in 1HY25

3.Care EBITDA per bed excluding capital gains

4
Oceania delivered a solid underlying result despite a persistently challenging residential housing market and tough economic conditions

Financial Highlights – six months to 30 September 2025

Dividend

The Directors have resolved not to declare an interim dividend.

The Directorsacknowledge the importance of dividends and arefocused on ensuring sustainability of Free Cashflow from Operations before resuming payments.

Financial Summary

1. Proforma EBITDA is adjusted for divestments and for the closure of the Wesley Institute of Nursing Education in April 2025.A reconciliation to the reported statutory figures is included in Appendix 03

Total Comprehensive

Income

$40.4m

Increaseof$28.6m

from $11.8m in 1HY25

Proforma Underlying

EBITDA

1

$41.9m

Increaseof23.2%

from $34.0m in 1HY25

Total Sales

Volume

271 units

Increase of 5.0%

from 258units in 1HY25

Operating

Cash Flow

$79.0m

Increaseof12.2%

from $70.4m in 1HY25

Total

Assets

$3.0b

Increase of 3.3%

from $2.9b at FY25

Net Tangible Assets

per Share

$1.57

Increase of 3.8%

from $1.51 at FY25

Net Debt

$608.9m

Decreaseof3.0%

from $628.0m at FY25

Gearing

34.8%

Decreaseof1.5%

from 36.3% at FY25

Sales Performance

6
The Helier, Auckland

•13 settlements achieved since March 2025, with an additional

seven units currently under application

1

•Premium product offering is increasingly aligned with

resident expectations

•The rate of sales applications has accelerated, rising from an

average ofless than two per month between March and

September to four per month since 1 October

•Independent Living Units (ILUs): 60% of units are either

occupied or under application

1

•Care suites: 41% of units are occupied or under

application

1

•Overall occupancy sits at 54.5%, including units currently

under application

1

•Full development cash recovery

2

is expected between March

and May 2026 based on sell down rates of between three and

four applications per month



Targeting full development cash recovery by 31 March 2026

3. Capital Management

2. Business Excellence

1. Sales Performance

1.As at20 November 2025

2.Includes cost of land, capitalised corporate costs andcapitalisedinterest costs

7
Solid start with 35.5% Stage1presales, driven by targeted marketing and early engagement. On track to open in January 2026 with Stage 2

forecast to commence in early FY27

Franklin, Auckland

3. Capital Management

2. Business Excellence

1. Sales Performance

31

Stage 1 statistics

Villas available31

Presales

1

11

Percentage presold35.5%

Presales $’m$11-$12m

Cost of development

2

c.$54m

Forecast cash return on full Franklin development

c. 16%

1.As at 20 November 2025. Presales are recognised as unconditional sales upon unit completion in January 2026 and on occupation of resident

2. Includes cost of land, capitalised corporate costs,capitalisedinterest costs, and $19m in relation to the construction of The Lodge

Villas & The Lodge

under construction

In September 2025, we purchased an additional3.7 ha, expanding the Franklin site to 11.6 ha

Settlement is conditional on rezoning and resource consent with stagedpaymentsforecastin March 2028, 2029 & 2030

Access to this land enables extension of the village by 78 villas

8
Opened in June 2025

55%

1

Occupancy achieved in first

four months

The dementia development concludes

the sixth and final stage of a key

integrated Auckland site

The final stage of the Meadowbank redevelopment was completed in 1HY26, occupancy has been tracking ahead of expectations

Meadowbank, Auckland

3. Capital Management

2. Business Excellence

1. Sales Performance

Dementia Suites

1. Occupancy as at20 November 2025, including PAC, respite residents, and under application

40

9
A total of 91 new sales were achieved for the

period,despite persistent challenges in the residential

housing market and broader economic headwinds

New Sales

5

28

42

38

39

33

36

51

52

34.6%

23.1%

34.4%

35.4%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

35.0%

40.0%

0

10

20

30

40

50

60

70

80

90

1HY231HY241HY251HY26

VillaApartmentCare SuiteDevelopment Margin

61

83

Care suite sales steady at 52

•Achieved 52 new sales of Occupation Rights, up from 51

in 1HY25

•Redwood care suites are now 81%

1

occupied, up from

62% in March 2025

Steady apartment sales

•Achieved 39 new sales of Occupation Rights, up from 38

in 1HY25

•Waterford’s new development is32%

1

sold down

Development marginsteady at 35.4%

•Margins remain supported by a consistent product mix

•Franklin villa residents taking occupation in January

2026, current villa presales will be recognised in 2HY26

599

949

867

1,088

1,121

306

361

358

391

1HY231HY241HY251HY26

VillaApartmentCare Suite

Average sales prices (new sales)

NZD000s

New sales volumes and development margin %

3. Capital Management

2. Business Excellence

1. Sales Performance

1. As at20 November 2025

89

91

10
Resales activity remained robust, led by consistent care

suite volumes and an uplift in apartment sales

Resales

Resale volumes remain steady

• Achieved 180 resales of Occupation Rights, up from

169 in 1HY25

•Care suites made up 61% of total resales, reflectingthe

strength of the product

•Apartment resales reached a record high with 36 achieved

in the period, up 50% on 1HY25

•Villa resales remained steady at 35 units

Resale margins moderated in 1HY26

•A higher proportion of regional resales has reduced the

average sales price relative to 1HY25, which included a

significant number of Auckland resales, particularly premium

units at Meadowbank

•36% of apartments sold in regional locations (13% 1HY25)

Average sales prices (resales)

NZD000s

639

582

647

806

914

829

329

363

370

1HY241HY251HY26

VillaApartmentCare Suite

Reales volumes and resale margin %

3. Capital Management

2. Business Excellence

1. Sales Performance

169

180

172

165

28

353535

24

20

24

36

113

117

110

109

22.7%

21.0%

21.5%

17.0%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

35.0%

40.0%

45.0%

50.0%

0

20

40

60

80

100

120

140

160

180

200

1HY231HY241HY251HY26

VillaApartmentCare SuiteResales Margin

11
FY25Development Stock AddedReduction in Unsold StockHY26

1. Based on CBRE Limited valuations – current ingoing price

2. Newly developed units currently occupied by residents under a PAC arrangement

The sell down of development stock has released net capital of $40m since March 2025

Development Stock

Value of unsold new stock

unavailable for immediate sale

2

Value of unsold new stock

completed within the last 12

months

Value of unsold new stock

completed over 12 months ago

$55m

$53m

$104m

$112m

$183m

$137m

$25m

($65m)

$302m

$342m

3. Capital Management

2. Business Excellence

1. Sales Performance

•The value of unsold development stock declined from

$342m at FY25 to $302m

1

in 1HY26, reflecting disciplined

portfolio management and stronger sales momentum

•This reduction occurred despite the completion of the 40

dementia suites at Meadowbank, adding approximately

$25m of new stock during the half

•Development ORA sales reached $65m during the period

•The Helier accounts for ~30% of the 1HY26 development

stock value. Other sites include Awatere,Waterford, The

Bayview, Meadowbank, Lady Allum and Elmwood

•Franklin is scheduled to deliver 31 villas in January 2026.

After allowing for presales to date, development stock will

increase by approximately $20m

Unsold development stock movement

from FY25 to 1HY26 $’m

1HY26

12
Site

Gross UnitsType

Franklin, Auckland

Stage 1

Stages 2-6

31

145 | 81

Villas

Villas | Care

Lady Allum, Auckland

Stage 2

Stage 3

69

68

Apartments

Apartments

Elmwood, Auckland

Stage 3

Stage 4

11

249

Villas

ILU

Bream Bay, Northland

Stage 1

Stage 2

23

127 | 60

Villas

Villas | Care

Waterford, Auckland

63 | 60ILU | Care

Gracelands, Hawkes Bay

61Villas

Optionality to support future development rate of 100-150 units per annum

Development Programme – Landbank of ~1,000 gross units

ConstructionConsentedPlanning

Final Stages

3. Capital Management

2. Business Excellence

1. Sales Performance

Further sites

in early design and

planning stages:

Stoke Nelson | 16 Villas

Franklin Auckland | 78 Villas

Duart Hawkes Bay | 50 Apartments

The Helier Auckland | Stage 2 - 16 Apartments

Eversley Hastings| 58 Care Suites

The Bayview Tauranga | Stage 4/5 – 107 Apartments| Stage 6 – 40 Dementia Suites

Business Excellence

14
1. A reconciliation to the reported statutory figures is included in Appendix 03

Over the past six months we have deliveredsignificant and sustained improvements inthe earnings of the continuing business

Proforma Underlying EBITDA

Proforma Underlying EBITDA and NPAT

1

NZD’m

Proforma

1HY26

Proforma

1HY25

Aged care operations12.18.4

Retirement village operations44.944.9

Other – corporate segment (15.1)(19.3)

Proforma Underlying EBITDA

1

41.934.0

Proforma Underlying NPAT

1

24.219.5

Statutory Comprehensive Income40.428.6

Care Earnings

Corporate Costs

44%

22%

•Increased occupancy

•Initial cost savings from

restructures and cost discipline

•Cost discipline

•Restructure of corporate office

complete – ready for growth

Village Earnings

•Villagesegment steady

despite market pressures

-

ProformaNormalisations:

•In April 2025 the Wesley Institute of Nursing Education was

closed. This function contributed $3.7m to underlying

EBITDA in 1HY25 and minor shutdown costs in 1HY26

•Divestments contributed EBITDA of$0.9min 1HY25 and

incurred costs of $0.1m in 1HY26

15
Care profitability per bed is up 40% half on half,

demonstrating that our commitment to care quality

and business excellence is delivering results

Driving Care Profitability

Care occupancy

•As leaders in care, we understand what residents value and how

to deliver it while maintaining strong, sustainable returns for our

shareholders

•EBITDA per bed excluding capital gains $12k, up from $9k per

bed in 1HY25,reflecting the early impacts of a renewed and

disciplined approach to operational execution

•Including care suite development margin and realised gains on

resales, EBITDA per bed $25k up from $12k per bed in 1HY25,

reflecting the sell-down of care suite stock

•Development margin on care suite new sales increased 41.3%,

reflecting the impact of a modernised care portfolio

•We expect this positive earnings trajectory to continue as we

progress our disciplined operational cost out programme across

the care portfolio

90.3%

91.6%

91.9%

92.2%

94.0%

94.7%

1HY241HY251HY26

Group OccupancyOccupancy of sites not affected by development

3. Capital Management

2. Business Excellence

1. Sales Performance

8,986

8,543

12,430

17,143

20,200

25,616

1HY241HY251HY26

Care EBITDA per bedCare EBITDA per bed including capital gains

Annualised care EBITDA per bed

16
3. Capital Management

2. Business Excellence

1. Sales Performance

The centralised corporate function is right sized and primed for growth

•Ongoing automation and simplification of processes are

improving efficiency across the corporate office

•Corporate office team right sized and primed for growth

with an annual staff cost reduction of approximately 20%.

•A refreshed Employee Value Proposition has been

launched to attract and retain purpose driven talent,

fostering a high performing, values led culture that delivers

exceptional care

•The team now focused on realising savings across the

wider business

•The Group delivered $4.0m in cost savings during

1HY26, with total savings of $13.2m expected by

year end

•Cost savings are expected to reach $20.4m on an

annualised basis from FY27

Right Sizing the Business

Capital
Management

18
Covenants met: ICR coverage of 2.5x

compared to the covenant of 2.0x

Gearing: Gearing reduced to 34.8%, within

range of 30 – 35%

Flexibility to repay debt: Oceania has the

flexibility to pay down core debt once a

development loan has been fully repaid

Headroom on current facilities: Headroom

of $116m on current banking facilities

Current average interest rate: (including

margin and hedging) on bank debt of 4.07%.

Fixed blended interest rate of 2.7% on $225m

of retail bonds expiring in FY28 and FY29

Debt facilities as at

30 September 2025

Facility limit

Drawn

amount

Headroom

General / corporate$185m$105m$80m

Development facility$315m$288m$27m

Retail Bonds$225m$225m-

Total limits / borrowings$725m$618m$107m

Cashn/a$9m$9m

Total net debt / headroom$609m$116m

1. Decrease largely due to lower cash earnings as a result of the sale of Wesley Institute of Nursing Education

Net debt and gearing have reduced to $609m and 34.8% respectively

Balance Sheet Management

Covenants

Debt

covenant

As at

1HY26

As at

FY25

Net debtn/a$609m$628m

Net debt / (net debt + equity)n/a34.8%36.3%

Loan to value ratio<50%35.4%37.8%

ICR

1

≥ 2.0x2.5x3.5x

3. Capital Management

2. Business Excellence

1. Sales Performance

19
The accelerated sell down of development stock is the largest lever to reduce debt, maintain gearingtargets and support growth

Development Debt

•Since the Initial Public Offering in 2017, total assets have increased through development and acquisition initiatives funded by debt

•We are executing a clear and disciplined strategy to reduce debt through the sell down of development and buy back stock, alongside strategic divestments

•The graphic below is an illustrative construct of reduction in debt only and not a forecast, it is intended to show the material reductions in debt and does not

overtly show future developments, land purchases, operating cash flow or future dividend payments

3. Capital Management

2. Business Excellence

1. Sales Performance

Illustrative debt reduction from

30 September 2025 position ($’m)

Target Gearing Mid

Point

Target Gearing

Mid Point

(40)

618

(302)

(43)

(30)

Total Debt Facility as at

Sept 2025

Development Unsold

Stock

Sale of Aged Buyback

Stock

Release of ORA debtors

Divestment Proceeds

Restrain Debt to Target

Gearing

Debt

Gearing

Range

84

900

618

3,000

Total DebtTotal Assets

Total debt and assets at

IPO vs. 1HY26 ($m)

IPO1HY26

288

105

225

20
In depth site by site analysis has guided divestment decisions, ensuring the right assets are released to unlock value and sharpen strategic focus

Divestments

3. Capital Management

2. Business Excellence

1. Sales Performance

The portfolio's average age is now < 15

years - ensuring all sites meet modern

standards remains akey priority

Geographically isolated sites within the

portfolio have, limited operational efficiency

and scalability

Ensuring care services are available at

all sites is a strategic priority across our

portfolio

1HY26 & FY25 divestments executed - $35m capital released

Another four sites under due diligence at circa. $40m, on track to settle in FY26

Criteria 1

Portfolio fit

Criteria 2

Location

Criteria 3

Care

WoburnTotara ParkOtumaramaVictoria PlaceTakaniniMiddleparkHolmwood

1HY262HY252HY251HY251HY251HY251HY25

21
Oceania has updated its dividendpolicy to better align dividends with operating cash flows

Free Cash Flow

•Interest on core debt: Interest related to non

development borrowings, referred to asinterest on

core debt, is included in cash flow from operating

activitiesin the cash flow statement

•ORA receivables: Free cash flow is affected by the

timing of resale ORA receipts. As at 30 September,

short term ORA receivables on resale units totaled

$30.3m, with $13.6m subsequently collected

•Buy backs: At 30 September 2025, approximately

~$43m of bought back aged stock was held. With a

renewed focus on resales, we expect to release this

stock over the next 6-12 months, providing a positive

contribution to operating free cash flow as other

initiatives embed

Free cash flow from operations, $’m1HY261HY25

Cash flow from operating activities – per financial

statements

79.070.4

Lessdevelopment ORA sales included in operating cash flow(61.9)(75.4)

Add back developmentbuybacks included in operating cash flow

0.35.9

Less lease principal payments

(1.1)(0.6)

Lessmaintenance and refurbishment capex

(11.7)(12.3)

Subtotal: Free Cash Flow from Operations before one offs4.6(12.0)

Lessone off: GST refund on development costs(14.0)

-

Add one off: Employment related restructure costs1.0

-

Free Cash Flow from Operations

(8.4)(12.0)

3. Capital Management

2. Business Excellence

1. Sales Performance

OCA’s dividend policy is to pay out between 40% and 60% of its Free Cash Flow from Operations.

Financials

23
1.Includes change in fair value of IP, other revenue, impairment of goodwill and impairment of PPE. See appendix 02

Total Comprehensive Income has increased by $28.6m, largely a result of revaluation gains

Profit and Loss

$m

1HY261HY25Var

Operating revenue131.6132.6(1.0)

Operating expenses (131.1)(133.5)2.4

Change in fair value of IP, impairment of PP&E

and other

1

26.43.522.9

Operating profit26.92.724.2

Finance costs(14.0)(11.8)(2.2)

Depreciation (buildings)(8.0)(6.9)(1.1)

Depreciation and amortisation (chattels and

other)

(3.9)(3.4)

(0.5)

Profit before income tax1.0(19.5)20.5

Taxation benefit3.92.41.5

Reported net profit after tax

4.9(17.1)

22.0

Other comprehensive income

35.528.9

6.6

Total comprehensive income

40.411.8

28.6

•Fair Value movements contributed $60.9m

to Total Comprehensive Income and

represents the impact ofincreased care and

village occupancy

•Finance Costs increased by 19%, driven

by interest on completed developments.

This reflects the usual progression of

projects from in construction to operational

and is consistent with accounting treatment

in prior years

•The Wesley Institute of Nursing

Education contributed $5.3m of operating

revenue, $1.6m operating expenses, and

$3.7m profit before tax in 1HY25. In 1HY26,

the only remaining item was $0.6m of

operating expenses

24
Cash Flow

Cash flow from operating activities increased by 12.3% to $79.0m in 1HY26, primarily driven by a one off GST adjustment

$m

1HY261HY25Var

Receipts from residents for village and care fees98.2106.0(7.8)

Payments to suppliers and employees(124.6)(129.4)4.9

Net occupational right agreements100.597.43.1

Net interest, goods and services tax and other4.9(3.6)8.5

Net cash inflow from operating activities79.070.48.7

Payments for PPE and intangible assets(9.0)(29.2)20.1

Payments for IP and IP under development(44.1)(45.6)3.4

Interest paid in relation to development borrowings(6.4)(10.7)4.3

Proceeds from sale and / or disposal of assets1.523.4(23.7)

Net cash outflow from investing activities(58.0)(62.2)4.1

Net borrowings(18.1)(2.1)(16.0)

Principal payment for lease liabilities(1.9)(0.6)(1.3)

Dividend paid0.00.0-

Net cash outflowfrom financing activities (20.0)(2.7)(17.3)

Net increase in cash and cash equivalents1.05.5(4.5)

Cash and cash equivalents at beginning of the period7.67.50.1

Cash and cash equivalents at end of the period8.613.0(4.4)

Net operating cash flows broadly consistent:

•Net operating cash flow was up 12.3% on prior period but

broadly flat when adjusted for the $14m GST refund on

construction costs

•Lower village and care fee receipts were broadly offset by

reduced supplier and employee payments

•Short term ORA receivables were elevated at balance date,

with $22.4m collected since period end

Investing Cash Flow

•Net investing cash flows eased on the prior period, with the

movement primarily driven by asset sales in 1HY25.

Excluding these, the reduction increases from ~7% to ~32%

•Elmwood and Meadowbank have now completed, with

Franklin the only development currently in progress,

reflecting the timing of the development cycle

Cash applied to repayment of debt:

•Cash generated from operating and investing activities

enabled a meaningful net repayment of $18.1m in

borrowings

25
•Total assets of more than $3.0b:Total

assets increased 3.4% from FY25 lifting

to over $3.0b, primarily driven by uplift in

property valuation through the impact of

increased care and village occupancy

•Refundable ORAs

increased:Refundable ORA liabilities

rose $64.4m (+5.8%), from FY25 levels

driven by improved sales activity,

demonstrating strong resident inflows and

sustained village occupancy

•Equity and NTA Strengthened:Total

equity and net tangible assets increased

by more than $41.0m, supported by

favourable revaluation gains

Balance Sheet

The balance sheet has continued to strengthen, with total assets now exceeding $3.0b and NTA per share increasing 3.8% since FY25

$m

1HY26FY25Var

Assets

Cash and trade receivables121.9126.1 (4.2)

Property assets2,902.42,800.5 101.9

Other assets13.314.1(0.8)

Total assets3,037.62,940.796.9

Liabilities

Refundable occupation right agreements1,171.21,106.864.4

Borrowings610.1 627.7(17.6)

Other liabilities113.5 104.39.2

Total liabilities1,894.81,838.856.0

Equity

Contributed Equity716.0 716.0 0.0

Retained Deficit12.67.0(5.6)

Reserves414.2378.8 35.4

Total equity1,142.81,101.841.0

Net tangible assets1,138.51,097.141.4

Looking forward

27
Measures of SuccessTargetResults as at 1HY26

CARE OCCUPANCY

Sustaining consistently high occupancy94.7%

1

BUILD RATE

100 to 150 units per annum

40 units at Meadowbank completed 1HY26

31 units at Franklinto becompleted in 2HY26

Total 71 units to be completed FY26

UNSOLD STOCK

Sell down of development stock< 2 yrs

Resale vacancy period< 9 mths

Sell down of development stock = 1.6 yrs

Resale vacancy period = 6 months

GEARING

Between 30 and 35%34.8%

DIVEST SITES

4-6 sites ~$50m proceeds

Four sites on track for settlement in

FY26 ~$40m proceeds

PURCHASE LAND

Extendgreenfield

land bank

11.6ha at Franklin, Auckland

RESIDENT

NET PROMOTER SCORE

Increase to 70+To be measured at March 2026

EMPLOYEE ENGAGEMENT

Increase to 70%+70%

GROWTH IN FREE CASH FLOW

FROM OPERATIONS

YoY Growth of Free Cash Flow

from Operations

($8.4m) +30% yoy

Clear performance measures underpin our approach to delivering sustainable growth and attractive shareholder returns

Measures of Success

DRAFT

1.Occupancy not affected by development

28
The Remainder of FY26

DRAFT

Sales Performance

•Increasing sales cadence and reducing our unsold

development and aged stock remains our key focus

•The Helier – momentum with applications – targeting

full development cash recovery by March 2026

•Franklin Stage 1 completed with presales above

current levels of 35%

Business Excellence

•Ongoing improvement in care profitability

•Cost savings of $13.2m to be achieved during FY26

•Further improvement on free cash flow from

operations

Capital Management

•Four divestments targeting $40m settlement in FY26

•Debt reduction supported by divestments and stock

sell down, with further reduction in gearing

Thank you

Appendices
01Underlying earnings

02Income Statement

03Proforma underlying earnings

04Cashflow

05Resales cash flow and capital expenditure

06Care Business

07Retirement Business

08Embedded value and affordability

09Balance sheet

10Future cash recycling

11Portfolio summary

12Future development outlook

13Development pipeline

14Available Stock

15Reconciliation of portfolio movements

16Summary of unit sales

17Our Strategic Framework

18Oceania Snapshot

19Definition of Underlying NPAT

20Glossary

21Important notice and disclaimer

31
01

Underlying EBITDA of $41.5m for the six month period ended 30 September 2025, a 7.5% increase on 1HY25

Underlying earnings

Reconciliation of underlying adjustments Segmental underlying

NZDm1HY261HY25VarFY25

Aged care operations12.08.63.520.4

Retirement village operations44.945.7(0.8)96.4

Other – corporate segment(15.4)(15.6)0.2(30.9)

Underlying EBITDA41.538.62.986.0

In FY25 Oceania refinanced its banking facilities which resulted in loan modification of a gain

of $5.4m . The gain and subsequent am ortisation is removed from Underlying NPAT in line

with our policy to rem ove fair value adjustm ents.

NZDm1HY261HY25VarFY25

Reported Net profit after tax4.9(17.1)22.030.4

less: Change in fair value of investment property (22.9)(26.1)3.2 (90.2)

less: Fair value of loan modification---

(5.4)

add: Amortisation offair value of loan modification0.7-0.7

-

add: Impairment of goodwill

0.1 0.2 (0.1)

0.2

add: Realised gains on resales

15.7 17.7 (1.9)

34.8

add: Realised development margin

22.7 20.5 2.2

48.3

less: Deferred tax

(3.9)(2.4)(1.5)

(4.6)

add: Care Suite Depreciation

6.8 5.7 1.1

11.8

Less: Insurance income on material damage due to

weather events

---

0.2

add: Impairment of PPE(2.2)26.0 (28.2)26.0

add: (Gain) / loss on sale of business assets including

associated costs and restructure costs

1.8(0.4)2.20.9

Underlying NPAT23.824.0 (0.2)52.5

add: Depreciation and amortisation (buildings)1.2 1.2 0.0 2.6

add: Depreciation and amortisation (chattels, leasehold

improvements & software)

3.9 3.4 0.4 7.7

add: Finance costs12.6 10.0 2.6 23.1

Underlying EBITDA41.5 38.6 2.986.0

32
02

Key valuation assumptions remained largely consistent from FY25 except for minor changes to incoming prices across all typologies

Income statement

Drivers1HY26FY25

Investment Property

PPGR – Long Term (low-high)

2.50% 3.50% 2.50% 3.50%

PPGR – Short Term (low-high)

- 3.00% - 3.00%

Discount Rates (low-high)

14.00% 20.00% 14.00% 20.00%

Average Incoming Price - Villas$669,976$654,109

Average Incoming Price - Apartments$1,078,064$1,080,126

Property, Plant and Equipment

Cap rate (low-high)12.25%15.00%12.25%15.00%

EBITDAR per bed (low-high, $000's)$9,231$24,578$9,305$52,060

Average Incoming Price - Care Suites$379,423$365,620

•Discount rate assumptions are unchanged from FY25.

•Minor changes to average in incoming price assumptions adopted by CBRE for villas,

apartments and care suites

Summary of income statement Key IP and PP&E CBRE valuation assumption changes

NZDm1HY261HY25VarFY25

Operating revenue131.6132.6(1.0)260.6

Change in fair value of investment property22.926.1(3.2)90.2

Other Revenue1.43.6(2.2)4.9

Total Income155.9162.3(6.4)355.7

Operating expenses (131.1)(133.5)2.4(260.6)

Impairment of goodwill(0.1)(0.2)0.1(0.2)

Impairment of property, plant and equipment2.2(26.0)28.2(26.0)

Total Expenses

(129.0)(159.7)

30.7(286.8)

Operating Profit

26.92.7

24.268.8

Finance costs(14.0)(11.8)(2.1)(20.8)

Depreciation (buildings)(8.0)(6.9)(1.1)(14.4)

Depreciation and amortisation (chattels and other)

(3.9)(3.4)

(0.4)(7.7)

Profit before Income tax

1.0(19.5)

20.525.9

Taxation benefit3.92.41.54.6

Reported Net Profit / (Loss) after Tax

4.9(17.1)

22.030.4

Other Comprehensive Income35.528.96.644.1

Total Comprehensive Income40.411.828.674.6

33
03

1. Includin g: Wobur n ( sold )

2. No adju stment h as bee n mad e in re latio n to acquisitio ns or develop me nt site s

3. Includin g Wob urn (sold)Takanini (sold),Holmwo od(sold),Middlep ark(sold), Victor ia P lace (sold) , Tota ra Park ( sold )

Proformaunderlying earnings for 1HY26 of $41.9m. Adjustments include normalising for the impact of divesting several sites from our ongoing

operations, as well as for the closure of the Wesley Institute of NursingEducation in April 2025

Proforma underlying earnings

Group proforma Underlying EBITDA and NPAT (1HY26)

Group proforma Underlying EBITDA and NPAT (1HY25)

Over the last 18 months to 30 September 2025 several sites have been divested

1,3

. The tables below show the unaudited Underlying Earnings attributed to these sites over the current and prior

comparative period. We present unaudited Proforma Underlying Earnings Before Interest, Tax, Depreciation and Amortisation, and Proforma Underlying Net Profit After Tax for both periods,

normalising for the impact ofdivesting of these sites from our ongoing operations. We have also normalisedfor the closure of the Wesley Institute of Nursing Education. Both of these measures

are Non-GAAP and unaudited.

$NZ000's1HY26Divested Sites

1

Wesley Institute of

Nursing Education

Proforma 1HY26

Aged Care Operations12.00.1-12.1

Retirement village

Operations

6.5--6.5

Resales Capital Gains15.7--15.7

Development Margin22.7--22.7

Other – corporate segment(15.4)-0.3(15.1)

Underlying EBITDA

2

41.50.10.341.9

Underlying NPAT

2

23.80.10.324.2

Existing ORAs Sold71--71

New ORA Sold39--39

Existing Care Suites Sold109--109

New Care Suites Sold52--52

Total ORA Sold271--271

NZDm1HY25

Divested

Sites

3

Wesley Institute of

Nursing Education

Normalised

1HY25

Aged care operations8.6(0.2)-8.4

Retirement village operations7.4(0.3)-7.1

Realised gains on resales17.7(0.4)-17.3

Realised development margin20.5--20.5

Other – corporate segment(15.6)-(3.7)(19.3)

Underlying EBITDA

2

38.6(0.9)(3.7)34.0

Underlying NPAT

2

24.0(0.8)(3.7)19.5

Villa and apartment resales 59(1)-58.0

Villa and apartment new sales38--38.0

Care suite resales110--110.0

Care suite new sales51--51.0

Total sales volume258(1)-257

34
04

Operating cash flow of $79.0m for the 6 months to 1HY26 compared to $70.4m in 1HY25

Cash flow

Statement of cash flows

NZDm

1HY261HY25VarFY25

Receipts from residents for village and care fees98.2106.0(7.8)201.0

Payments to suppliers and employees(124.6)(129.4)4.9(266.1)

Receipts from new occupation right agreements156.8168.1(11.3)294.5

Payments for outgoing occupation right agreements(56.3)(70.7)14.4(106.6)

Net goods and services tax received / (paid)12.20.112.0(1.9)

Receipts from insurance proceeds0.44.4(4.0)4.7

Interest received0.61.8(1.2)3.1

Interest paid in relation to general borrowings(8.0)(9.6)1.6(17.7)

Interest paid in relation to right of use assets(0.4)(0.4)-(0.8)

Net cash inflow from operating activities79.070.48.7110.3

Payments for property, plant and equipment and

intangible assets

(9.0)(29.2)20.1(39.8)

Payments for investment property and investment

property under development

(44.1)(45.6)3.4(73.7)

Proceeds from sale of assets1.523.4(23.7)32.1

Interest paid in relation to development borrowings(6.4)(10.3)3.9(18.4)

Payments for assets held for sale-(0.4)0.4(0.4)

Net cash outflow from investing activities(58.0)(62.2)4.1(100.3)

Proceeds from borrowings34.562.3(27.8)102.0

Repayment of borrowings(52.6)(64.4)11.8(110.4)

Principal payments for lease liabilities(1.1)(0.6)(0.5)(1.5)

Loan refinancing fees(0.8)-(0.8)-

Net cash inflow from financing activities (20.0)(2.7)(17.3)(9.9)

Net increase in cash and cash equivalents1.05.5(4.5)0.1

Net cashflows from operating activities

NZDm

57.2

70.4

79.0

HY24 HY25 HY26

35
05

1. Net Buybacks is the differ ence b etween the gross O RA pa yments mad e in re latio n to units bo ught b ack (and not resold) during the year and the gross O RA receipts from units re sold du ring th e year that wer e b ought back in prior financial ye ars

Growth in resales cash flows as Oceania’s portfolio matures and resells at higher price points

Reconciliation of resales cash flow and capital expenditure

Reconciliation of resales cash flow

•Net resales cashflow for 1HY26 of $38.7m, up 76% on 1HY25

•This is driven primarily by the reduction in buybacks from 1HY25

Breakdown of Capital Expenditure

NZ$m1HY261HY25

Disposals(1.5) (23.4)

Development capital expenditure41.462.6

Maintenance capital expenditure

- Care suite refurbishment 1.0 1.0

- Other aged care2.9 2.4

- Retirement village refurbishment5.0 6.8

- Other retirement village2.41.3

- IT and other0.4 0.8

Total refurbishment and maintenance11.712.2

Total capex per statutory cashflow statement51.6 51.5

NZD $m’s

1HY261HY25

Receipts from New ORAs

156.8

168.1

less: Payments for Outgoing ORAs

(56.3)

(70.7)

less: Cash Inflow From New Sales

(61.9)

(75.4)

Net Resales Cash flow

38.7

22.0

Made up of :

Resale Gains

15.717.7

DMF Realised

15.922.7

Add: Net Deferred Cash Settlements

1.58.0

less: Development Buybacks

(0.3)(5.9)

less: Net Buybacks

3.7(17.7)

less: Resident Share of Capital Gains

-(0.9)

less: Other Cash amounts paid/received from resales

2.1(1.9)

Net Cash flows from Resales

38.722.0

36
06

1. Develop me nt margin an d r esa le g ains on care suites are include d within th e V illage Segment fo r u nderlying profit a nd statutory r eporting purp ose s as the ORAs are issued by Oceania Villag e Compan y Limited. As th ese marg ins are in lieu of daily pr emium

charge s unde r the traditional model, th ese ea rnings are aggre gated above to pre sen t a more co mp lete picture for the Care Seg ment

Care business increases by 45% from 1HY25 for EBITDA per bed

Care business

NZDm1HY261HY25Var

Daily care fees87.3 86.2 1.1

PAC revenue4.2 3.7 0.5

Care suite DMF9.6 8.6 0.9

Other revenue2.2 2.3 (0.1)

Total aged care operating revenue ($m)103.3 100.9 2.4

Staff and resident expenses(71.9)(70.2)(1.7)

Occupancy and site overhead expenses(19.4)(22.2)2.8

Total aged care expenses(91.3)(92.4)1.1

Aged Care Underlying EBITDA12.08.6 3.5

EBITDA per care bed / suite ($k)

12,4308,5433,887

Plus: Other aged care related earnings included within the Village Segment

1

Care suite development margin8.9 5.93.0

Care suite resale gains3.9 5.8 (1.9)

Aged care related underlying EBITDA24.820.2 4.6

Aged care related underlying EBITDA per

bed ($k)

25,616 20,200 5,416

Revenue growth driven by stronger DMF and care fees

•Total aged care operating revenue increased +2.4m (+2%) to $103.3m.

•PAC revenue also improved (+$0.5m), while other revenue remained stable.

Cost discipline led to improved expense profile

•Overall aged care expenses improved $1.1m, reducing to ($91.3m) driven by

occupancy and site overhead expenses decreasing.

Underlying EBITDA materially up, with strong per-unit improvement

•EBITDA per care bed/ suite improved significantly to $12,430 from $8,543 (+45%).

103.2

100.9

103.3

9.9 8.6

12.4

9.6%

8.5%

11.2%

18%

20%

24%

1HY20241HY20251HY2026

RevenueEBITDAEBITDA marginEBITDA margin (cap gains incl.)

37
07

Total Retirement Village operating income increases by $1.5m

Retirement village business

NZDm

1HY261HY25VAR

Villa and Apartment DMF

21.920.71.2

Retirement village service fees

5.85.30.5

Other revenue

1.51.6(0.1)

Total retirement village operating revenue

29.127.61.5

Realised gains on resales

15.717.7(2.0)

Realised development margin

22.720.52.2

Total retirement village expenses

(22.6)(20.1)(2.5)

Retirement village underlying EBITDA

44.945.7(0.9)

Total resale volume

18016911

Total new sales volume

91892

Total sales volume

271258

Less: Aged care related earnings included within the Village Segment

Care suite development margin & resale gains

(11.4)(11.7)0.2

Retirement village underlying EBITDA (ex

care)

33.434.1(0.6)

Village Occupancy

83.7%

from 82.7% in FY25

80

82

84

86

88

90

FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Average of Age at Entry

0

50

100

150

200

250

<11- 2

Years

2- 3

years

3-4

years

4-5

years

5-6

years

6-7

years

7-8

years

8-9

years

9-10

years

10-11

years

11- 12

years

12-13

years

13+

Average Tenure

ApartmentVillasCare Suites

38
08

1. Calculated as the curre nt / e stimated sale or re sale pr ice of all u nits / care suite s as d ete rmined by CBRE Limited .

2. Value of u nso ld stock repr ese nts th e sales prices of units / care suites which are not u nder contract, as they a re eith er newly constructe d o r h ave be en bought back from the pr evio us outgoin g r esid ents.

The embedded value in our portfolio has increased 12% since 1HY25 to $615.2m as at 1HY26 and will underpin the future realisation of cash

flows from deferred management fees and resale gains

CBRE embedded value and affordability ratio

Summary of Embedded Value Calculation

Embedded Value

NZDm

•Embedded value in Oceania’s portfolio is $615.2m, up 12% since 1HY25.

•Embedded value includes:

•$249.3m of accrued DM F cash flows to be realised; and

•$365.9m of resale gains.

•The growth in em bedded value reflects growth in our portfolio, migration to our

standard contractual terms at existing villages and a higher price point for the sale and

resale of units and care suites.

NZ$m1HY26 1HY25

Var

Estimated sale / resale price of all Units

1

2,087.3 1,909.3

9%

less: Unsold stock

2

(352.7)(360.6)

2%

less: Resident liabilities (contractual)

(1,119.4)(997.1)

12%

equals: Embedded value

615.2 551.6

12%

Average CBRE affordability ratio of Oceania residences

249.3 220.5

365.9

331.1

2,486

2,483

-

600

1,200

1,800

2,400

3,000

-

100

200

300

400

500

600

1HY20261HY2025

Accrued DMFEmbedded Resales GainsTotal number of units (rhs)

82.6%

75.2%

35.1%

ApartmentsVillasCare Suites

1HY26

1HY25

39
Balance sheet

NZ$m

1HY26FY25

Assets

Cash and trade receivables121.9125.4

Property, plant and equipment868.0828.5

Investment properties2,034.31,972.0

Derivative Financial Instruments0.20.7

Intangible assets4.24.7

Right to Use Assets8.99.4

Total assets3,037.62,940.7

Liabilities

Trade, other payables and provisions48.036.4

Deferred management fees 55.457.3

Refundable occupation right agreements1,171.21,106.8

Borrowings610.1627.7

Lease Liabilities10.210.6

Total liabilities1,894.81,838.8

Equity

Contributed Equity716.0716.0

Retained Deficit12.67.0

Reserves414.2378.8

Total equity1,142.71,101.8

Net tangible assets1,138.51,097.1

09

Total assets increased by $97m from 31 March 2025. Oceania’s net adjusted value is $1.50 per share as at 30 September 2025

Balance sheet

•Current headroom in bank facilities (plus cash) of $116.1m .

•The NAV reflects the value of existing sites, plus the land and WIP at development

sites. As such, the present value of net developm ent cash flows and future earnings at

developm ent sites are excluded.

NZ$m

1HY26FY25

PP&E (inc WIP)868.0

828.5

IP & ROU Assets (incl WIP)2,043.2

1,981.4

Sub Total2,911.3

2,809.9

less ORA Gross Up(963.6)

(913.1)

add: Adj for CBRE –Care Suites(210.0)

(197.3)

add: Other(41.0)

(33.6)

CBRE plus WIP1,696.7

1,665.8

less: Net Debt(608.9)

(628.0)

Net Adjusted Value1,087.7

1,037.8

Shares on Issue724.2

724.2

Net Adjusted Value per Share1.50

1.43

Netadjustedvalue(“NAV”)

40
10

1. T he development debt bala nce i ncl udes The Hel ier , Elmwood ca re suit es, Redwood care suites, Wa terford, Mea dowbank Dementia,and Awat er e a par tments (sta ge 3)

2. T he estim ated va lue of 31 ILU units a t Fr ankli n to be completed in 2HY 26

3. T he future a nd cur rent dev elopm ent debt a nd associ ated va lue i ncl udes the land a t Fr anklin, Bream Bay , Gra cel ands a nd W oodlands, plus WIP ba lances at Fra nklin

Oceania’s debt is primarily development related, supported by current and future new sales stock, providing a clear path to debt repayment. In

aggregate we have $102.1m of asset coverage to our current development related debt

Future cash recycling

Development debt from completed (but not yet fully repaid)

1


developments to underlying development assets (NZDm)

Development debt – future and current developments

•$7.2m / 1.08x coverage from land and WIP values

•Faster cash recycling from villa products in the medium term

Development debt – completed sites in sell down

•Our unsold new stock will be used to repay development debt, with

excess proceeds of $94.9m available to pay down working capital

borrowings or additional development borrowings

Development debt from land purchases and developments under

construction

3

to underlying development assets

3

(NZDm)

26.9 26.9

54.3

61.5

81.2

88.4

Development debt from projects

under construction and land purchases

Value of related land assets and WIP

WIPTotal

207.4

302.3

Development debt

from completed developments as at September

2025

Value of unsold new stock as at September

2025

41
SiteRegionCare bedsCare suitesVillage unitsTotal

NORTH ISLAND

Bream BayRuakaka- - 83 83

The SandsNorth Shore-4464108

Lady AllumNorth Shore1796116229

Te ManaNorth Shore4646

WaterfordWaitakere150150

The Helier

1

Auckland3279111

Remuera RiseAuckland125971

EdenAuckland6689155

MeadowbankAuckland104193297

ElmwoodManukau104116220

St Johns AucklandManukau1818

FranklinFranklin443377

AwatereHamilton90171261

WhitiangaWhitianga541064

ElmswoodTauranga3636

The BayViewTauranga81156237

OhinemuriPaeroa68876

St Johns WoodTaupo3944184

WharerangiTaupo472168

DuartHastings6666

EversleyHastings50656

GracelandsHastings7711119207

AtawhaiNapier523146129

EldonParaparaumu8114196

EldersleaUpper Hutt982512135

HeretaungaUpper Hutt382058

Hutt GablesUpper Hutt4646

SiteRegionCare bedsCare suitesVillage unitsTotal

SOUTH ISLAND

Marina CovePicton3232

Green GablesNelson6140101

StokeNelson105105

RedwoodBlenheim177346136

WoodlandsTasman23343693

Palm GroveChristchurch275732116

The OaksChristchurch644032136

The BellevueChristchurch7168139

AddingtonChristchurch722597

TOTAL (NORTH AND SOUTH ISLANDS)

1,0281,1231,9884,139

11

1. 1 u nit at The Helier has been converted to an activities room, availab le u nits co me to 110

Asat30 September2025

Portfolio summary

42
Care bedsCare suitesILUsTotal

North Island8257621,5973,184

South Island203361391955

Total Existing1,0281,1231,9884,139

Development Pipeline-2991,1071,406

Less Decommissions

(44)(90)(134)

Care Suite Conversions

Net Development Pipeline

2551,0181,273

Total Post Development

1,0281,3783,0055,412

12

1. As at 30 September 2025

We have 1,406 units in the development pipeline that we will take a measured and disciplined approach on when to execute

Future development outlook

Current& futureportfoliocomposition

1

Existingportfolio

Development pipeline

Postdevelopmentportfolio

32%

68%

2,814

Premium

1,325

Standard

22%

78%

4,220

1,191

Standard

26%

24%

50%

1,988

RV units

1,028

Care

Beds

1,123

Care

Suites

22%

78%

2%

39%

59%

19%

25%

56%

824

Planned

31 Under

Construction

551

Consented

3,005

RV units

1,028

Care

Beds

1,378

Care

Suites

1,107

RV units

299

Care

Suites

43
Status as at 30 September 2025

SitesStageStatusILUsCare suitesGross unitsNet units

Franklin

Stage 1

Under Construction31-3131

Stage 2-6

Consented14581226181

Stage 7

Planned78-7878

Lady Allum

Stage 2

Consented69

-

6969

Stage 3

Consented68-6868

The BayView

Stages 4-6

Consented107-107107

EversleyConsented-585852

Bream Bay

Stage 1

Consented23

-

2323

Stage 2

Planned12760187187

Waterford

Stage 2

Planned24608484

Stage 3

39-3933

GracelandsPlanned61-6159

Elmwood

Stage 2-3

Planned11

-

111

Stage 4+

Planned249

-

249249

Other

DuartPlanned50-50(1)

1

The HelierPlanned16-1616

StokePlanned16-16(6)

2

BayviewPlanned-404040

Total Consented / under construction

443139582532

Total Pipeline1,1072991,4061,273

13

Development pipeline

1. Car e B eds will be decommissioned for development

2. Old 1 bed co ttages th at will b e d emolish ed to allow fo r n ew villas to be built

44
14

Breakdown of available stock comparison of September 2025 to March 2025

Available Stock

As at Sept 2025As at March 2025

Available Resale

1

5858

Under Application- Resale

1514

Total

7372

Available Resale

76

Under Application- Resale

24

Villa

910

Available Resale

1315

Under Application- Resale

109

Apartments

2324

Available Resale

3837

Under Application- Resale

31

Care Suites

4138

1. Ava ilable Re sale stock ismade up of Develop me nt Buybacks, Available Resa les, Un der Re fur bish me nt and Development Tr ansfer s

As at Sept 2025As at March 2025

Available New

245270

Under Application- New

2622

Total

271292

Available New

00

Under Application- New

00

Villa

00

Available New

151208

Under Application- New

2214

Apartments

173222

Available New

9462

Under Application- New

48

Care Suites

9870

45
15

Totals as at 30 Sep tembe r 2 025 reconcile to both the total existing and future post de velo pment po rtfolios at ap pendix 09.

Reconciliation of portfolio movements

Movements in gross pipeline since FY25

As at

FY25

Changes

in existing

capacity

Conversion

of beds to

care suites

Conversion

of units to

care suites

New units

acquired

New units

delivered

Changes in

pipeline – gross

units added

Changes in

pipeline –

decommissions

As at

1HY26

Existing

Care beds

1,068(40)1,028

Care suites

1,090(7)401,123

Units

2,003(15)1,988

Pipeline

Care beds

(111)

(111)

-

Care suites

518(40)

(267)44

255

Units

714

21490

1,018

Total

5,282(62)----

(164)134

5,412

1,284

1,273

78 Units

16 Units

154 Units

(40) Units

(30) Units

119 Units

FY2025Add: Franklin land acquiredAdd: The Helier masterplanAdd: Elmwood masterplanning

update

Less: Meadowbank completedDivestmentsOther net

movements

HY2026

46
Resales

1HY221HY231HY241HY251HY26

Villa

2728353535

Apartment

1824202436

Care suite

84113117110109

Total

129165172169180

Average resale margin

19.6%22.7%19.8%21.5%17.0%

New Sales

1HY221HY231HY241HY251HY26

Villa

130500

Apartment

4428423839

Care suite

4433365152

Total

10161838991

Average development margin

26.0%34.6%24.8%36.2%35.4%

Average resale gain per unit / care suite

1HY221HY231HY241HY251HY26

Villa

182,352242,969210,414231,601238,514

Apartment

135,333198,375135,950157,75098,278

Care suite

39,03643,11543,76952,39135,330

Average resale gain

82,46999,61388,398104,46887,428

16

Summary of unit sales

47
17

This framework brings everything together - connecting purpose, pillars and performance

Our Strategic Framework

Supporting and empowering people to live well as they age

Year on Year growth in free cash flow and underlying earnings

Our Purpose

Strategic Objectives

Strategic Initiatives

Mid Point - KPIs

Enablers

Customer Choice

Future Development

Service Expansion

Connected Care

Seamless care and trusted

relationships

Inspired Living

Elevating lifestyle, wellbeing

and choice

Empowered People

High performing and engaged

workforce

Purposeful Impact

Sustainable growth through

innovation

Resident Net Promoter

Score > 70

Sustaining consistently

high occupancy

Employee engagement

levels > 70%

Development sell down

< 2 years (including

20% presales)

Transformation & Innovation

Clinical Governance & Quality

Sustainability & ESG

48
18

Oceania have experienced significant growth since IPO with a $2.1 billionincrease in total assets

Oceania Snapshot

2017

IPO

1HY251HY26 Change v IPO

Care units52%54%52%0%

Independent living units48%46%48%0%

Total assets$0.9b$2.8b$3.0b

+ $2.1b

NTA per share$0.92$1.43$1.57+ 71%

Total unsold stock (inc

resales)

$34m$361m$352m+ $318m

Total debt$84m$642m$618m+ $534m

Gearing15.0%37.5%34.8%+ 19.8 pp

Share price$0.79$0.78$0.82+4%

P/NTA1.1x0.5x0.5x(0.6x)

Substantial growth:

•Assets have risen to $3.0b from $0.9b at IPO

•NTA per share has increased 71% since IPO,

driven by significant expansion in village and care

Stronger platform:

•following this period of expansion, gearing has

dropped substantially, tracking toward the middle

of our 30-35% target

Improved capital efficiency:

•Build activity and disciplined land utilisation during

the period since IPO have driven stronger

recurring earnings and future cash flow generation

49
19

Definition of Underlying NPAT

Underlying net profit after tax ("Underlying Profit")

Underlying Profit and Underlying EBITDAare non-GAAP measures of financial performance. The

calculation of Underlying Profit and Underlying EBITDArequires a number ofestimates to be approved

the Directors in their preparation. Both the methodology and the estimates may differ among companies

in the retirement village sector.Underlying Profit and Underlying EBITDA do not represent cash flow

generated during the period.

The Group calculates Underlying Profit and Underlying EBITDA by making the following adjustments to

reported Net Profit after Tax:

•Removing fair value adjustments for investment property assets, property, plant and equipment, held

for sale assets and financial instruments;

•Adding back impairment of goodwill;

•Add back / remove loss / gain on sale, decommissioning or purchase of assets and business assets

including associated costs and staff redundancy costs in the instance of a significant restructure or

change to the business model;

•Addback depreciation (care suites);

•Remove insurance income recognised in relation to material damage due to adverse weather events;

•Add backDirectors' estimate of realised gains on the resale of units and care suitessold under an

ORA;

•Add back Directors' estimate of realised development margin on the first sale of new ORA units or

care suites following the developmentof an ORA unit or care suite, conversion of an existing care

bed to a care suite or conversion of a rental unit to an ORA unit;

•Add back deferred taxation component of taxation expense so that currenttax expense is reflected;

•Remove interest income;

•Add backfinance costs (includinglease interest under IFRS16 Leases but excluding fair value of

loan modification and hedge ineffectiveness);

•Add back depreciation and amortisation(including right of useproperty, plant and equipment);

•Add back current tax expense

Resale Gain

Directors’ estimate of realised gains on resales of ORA units and care suites (i.e. the difference

between the incoming residents ORA licence payment and the ORA licence payment previously

received from the outgoing resident) is calculated as the net cash flow received, and receivable, at the

point that the ORA contract becomes unconditional and has either ‘cooled off’ or where the resident is in

occupation at balance date.

Development Margin

The Directors’ estimate of realised development margin is calculated as the cash received, and

receivable, in relation to the first sale of new ORA units and care suites, at the point that the ORA

contract becomes unconditional and has either ‘cooled off’ or where the resident is in occupation at

balance date, less the development costs associated with developing the ORA units and care suites.

•Construction costs directly attributable to the relevant project, including any required infrastructure

(e.g. roading) and amenities related to the units (e.g. landscaping) as well as any demolition and site

preparation costs associated with the project. The costs are apportioned between the ORA units and

care suites, in aggregate, using estimates provided by the project quantity surveyor. The construction

costs for the individual ORA units or care suites sold are determined on a pro-rated basis using gross

floor areas of the ORA units and care suites;

•An apportionment of land valued based on the gross floor area of the ORA units and care suites

developed. The value for Brownfield development land is the estimated fair value of land at the time

a change of use occurred (from operating as a care facility or retirement village to a development

site), as assessed by an external independent valuer. Greenfield development land is valued at

historical cost; and

•Capitalised interest costs to the date of project completion apportioned using the gross floor area of

ORA units and care suites developed.

Development costs do not include:

•Construction, land (apportioned on a gross floor area basis) and interest costs associated with

common areas and amenities or any operational or administrative areas.

The Directors’ estimate of development margin for conversions of care beds to care suites and rental

units to ORAs is calculated based on the difference between the ORA licence payment received on the

settlement of sales of newly converted ORA units and care suites and the associated conversion costs.

Conversion costs comprise:

•In the case of conversion of care beds to care suites, the actual refurbishment costs incurred; and

•In the case of conversions of rental units to ORA units, the actual refurbishment costs incurred and

the fair value of the rental unit prior to conversion.

50
20

Glossary

Care Suite

A room or studio certified for the provision of care by the Ministry of Health which has been licensed

under an ORA.

DMF

Deferred Management Fees, charged under an ORA, of a maximum of 30% of the Occupation Licence

Payment, which are deducted from the refund paid to the departing resident upon resale of the unit or

care suite. These are in consideration for the right to use communal facilities etc over the entire length

of stay.

EBITDA

Earnings Before Interest, Tax, Depreciation and Amortisation

FY25

12 month audited financial year

1HY26

Current financial period

1HY25

Priorfinancial period

ILU

Independent living units (villas and apartments) licensed under an ORA.

IP

Investment Property.

IPO

Initial Public Offering (of shares in Oceania).

NPAT

Net Profit After Tax

ORA

An occupation right agreement that confers on a resident the right to occupy a unit or care suite subject

to certain terms and conditions set out in the agreement.

PAC

Premium accommodation charge on a care bed for accommodation provided above the mandated

minimum.

PPE

Property, Plant and Equipment.

PPGR

Property Price Growth Rate.

Resale Margin

Resale gain, as included in the definition of underlying profit, divided by the ORA licence payment

previously received from the outgoing resident.

Unit

Includes independent villas and apartments.

WIP

Work in progress.

51
21

Important notice and disclaimer

This presentation has been prepared solely by Oceania Healthcare Limited ("Oceania"). You

must read this disclaimer before making any use of this presentation and the accompanying

material or any inform ation contained in it ("Docum ent").

The presentation includes non-GAAP financial measures for developm ent sales and resales

which assist the reader with understanding the volumes of units settled during the period and

the impact that development sales and resales during the period had on occupancy as at the

end of the period.

The addition of totals and subtotal within tables and percentage m ovements may differ due to

rounding.

The inform ation set out in this Document is an overview and does not contain all information

necessary to make an investment decision. It is intended to constitute a summary of certain

information relating to the performance of Oceania for the period ending 30 September 2025.

Please refer to the Interim Financial Statements for the period ended 30 September 2025 that

have been released along with this presentation.

The inform ation in this presentation does not purport to be a complete description of Oceania.

In making investment decisions, investors must rely on their own exam ination of Oceania,

including the merits and risks involved. Investors should consult their own legal, tax and/or

financial advisors in connection with any acquisition of financial products.

The inform ation contained in this presentation has been prepared in good faith by Oceania.

No representation or warranty, expressed or implied, is made to the accuracy, adequacy or

reliability of any statements, estimates or opinions or other information contained in this

presentation, any of which may change without notice. To the maximum extent permitted by

law, Oceania, its directors, officers, employees and agents disclaim all liability and

responsibility (including without limitation any liability arising from fault or negligence on the

part of Oceania, its directors, officers, employees and agents) for any direct or indirect loss or

damage which may be suffered by any person through the use of or reliance on anything

contained in, or omitted from, this presentation.

This presentation is not a product disclosure statement, prospectus, investm ent statement or

disclosure document, or an offer of shares for subscription, or sale, in any jurisdiction.

Receipt of this Document and/or attendance at this presentation constitutes acceptance of the

terms set out above in this disclaim er.

---

Oceania Healthcare 1HY26 Results Announcement

Momentum Building on Stronger Foundations

Oceania Healthcare (NZX:OCA) has delivered a much improved result for the six months ended

30 September 2025, reflecting disciplined execution and sustained momentum across its

strategic priorities of sales performance, business excellence, and capital management.

Improved sales conversion, cost efficiencies, and a sharper focus on working capital have

strengthened operating cash flow. Gearing has reduced to within target range and the business

is well positioned for further sustainable improvement in the second half.

Financial and Operating Highlights

1


• Total Comprehensive Income: $40.4 million, up $28.6m on 1HY25

• Reported NPAT: $4.9m, compared to a loss ($17.1 million) in 1HY25

• Proforma Underlying EBITDA

2

: $41.8 million, up 19.7% on 1HY25

• Proforma Underlying NPAT

2

: $24.1 million, up 18.9% on 1HY25

• Free Cash Flow from Operations: $(8.4) million, 30.0% improvement from 1HY25

• Annualised cost savings: $20.4 million identified, with $4.0 million delivered in 1HY26 and

on track to deliver $13.2m in FY26

• Care EBITDA per bed: up 45.5% to $12.4k, reflecting a renewed and disciplined approach

to operational excellence and strong sales of care suites

• Total assets: increased to $3.0 billion, up 3.3% on FY25

• Net tangible assets: $1.57 per share, a 3.8% increase on FY25

• Gearing: 34.8%, down 1.5 percentage points from March 2025 and within the target range of

30 – 35%

Sales performance

Sales performance strengthened through the period, underpinned by targeted initiatives to

improve conversion rates and reduce unsold stock. Total sales volumes rose 5.0% to 271 units,

reflecting broad based momentum across the portfolio. Sustained demand for care suites

delivered 161 sales in line with the prior period. Independent living unit sales improved, rising

13.4% to 110 units. At The Helier, in Auckland, sales continue to improve, with 54.5% of

residences either occupied or under application as at 20 November 2025 and targeting full cash

recovery, including interest, by 31 March 2026. Enquiry and conversion levels continue to build,

reflecting growing market recognition of The Helier’s full range of living options combined with

its premium resident experience.

At Franklin, in Auckland, presales continued to build strongly, with 11 villa sales secured to date

ahead of completion. Construction remains on schedule, with 31 independent living units set to

welcome their first residents in January 2026.

Suzanne Dvorak CEO said “The early sales success at our Franklin development reflects the

growing strength of Oceania’s sales capability, with product design, pricing, and location

increasingly aligned to customer demand. The project illustrates the effectiveness of Oceania’s

disciplined approach to development.”


1

All balances have been extracted from the 30 September 2025 interim financial statements and are unaudited.

2

Underlying NPAT and Underlying EBITDA are non-GAAP measures of financial performance. The calculation of Underlying NPAT

and Underlying EBITDA requires a number of estimates to be approved by the Directors in their preparation. Both the methodology

and the estimates may differ among companies in the retirement village sector. A reconciliation of Reported NPAT to Underlying

NPAT and Underlying EBITDA is included in Note 2.1 of the Interim Report. Proforma Underlying NPAT and Proforma Underlying

EBITDA are adjusted for the impact of the closure of the Wesley Institute of Nursing Education in April 2025. A reconciliation of

Underlying NPAT and Underlying EBITDA to Proforma NPAT and Proforma EBITDA is included on page 9 of the Interim Report.

Oceania Healthcare 1HY26 Results Announcement

Financial Performance

Total Comprehensive Income was $40.4m, up $28.6m, reflecting the initial positive impacts of

the cost out programme and the impact of fair value gains. Operating Cash Flow increased to

$79.0 million, up 12.2% compared to $70.4m in 1HY25. This was driven by higher cash receipts

from occupation right agreements (ORAs), up 3.2% on the prior corresponding period,

supported by lower payments to suppliers and employees, down 3.8% on the prior

corresponding period. The care segment recorded a 40% increase in underlying EBITDA

compared with the prior period, supported by enhanced clinical systems, digital workflow tools,

and refined acuity management. Annualised care EBITDA per bed, excluding resale gains, rose

to $12.4k, up 45.5%, with more than half of the portfolio generating over $15.0k per bed per

annum.

Proforma Underlying EBITDA was $41.8m for the 6 months ended 30 September 2025. This

included total capital gains of $38.4m, an increase of $0.2m on the previous year.

Gearing reduced to 34.8%, down from 36.3% at 31 March 2025, leaving undrawn net debt

headroom of $116.1m at 30 September 2025 as planned.

Interim Dividend

The Board announced a new dividend policy in June 2025 to align with operating cashflows and

targeting a payout ratio of between 40 and 60% of Free Cashflow from Operations, subject to

capital requirements and investment opportunities.

Chair, Liz Coutts advises that “The Board has decided not to declare an interim dividend for

1HY26, in line with the policy. Dividend payments are expected to resume when the business

achieves positive free cash flow from operations, supporting a return to payment of dividends.”

Strategy and Outlook

Oceania Healthcare’s strategic direction is clear and in motion. In September, the company

hosted a well-attended Investor Day for institutional investors and equity analysts.

The near-term priorities of Sales Performance, Business Excellence, and Capital

Management outlined on the day are being executed with discipline.

Mrs Coutts said “Oceania is first strengthening its foundations to position the business for its

next phase of growth. The longer-term strategic horizon (FY27–FY31) will build on these

foundations, focusing on customer choice, service expansion, and future development.”

Oceania’s land bank and operational footprint provide significant optionality, and development

activity will continue to be paced to align with market conditions and capital availability. The

company is taking a disciplined approach to growth, building only when and where conditions

are right. It will build towards its target of 100-150 units per year over the near term.

For the remainder of FY26, the focus is on executing these foundations with precision.

Increasing sales cadence and reducing debt remain central to this effort. Key operational

priorities include:

• strong sales at The Helier, targeting full recovery of development costs by March 2026;

• completing Stage One at Franklin with increasing presales (currently at 35.5%);

• further improving care profitability;

Oceania Healthcare 1HY26 Results Announcement

• implementing $20.4 million in annualised cost-out initiatives from FY27;

• completing four planned divestments targeting ~$40 million in capital release;

• delivering significant debt reduction to maintain gearing within the targeted range of 30 –

35%; and

• returning to positive free cash flow from operations and resuming the payment of dividends.

Ms Dvorak said: “We have acted quickly and decisively as a leadership team. The progress over

this focused period of execution ensures Oceania enters the next stage of its strategy with

stronger cash generation, a leaner cost base, and the balance sheet strength to pursue

disciplined, value-accretive growth. Oceania enters 2HY26 with significantly improved sales,

financial, and operational momentum.

We said we'd strengthen sales, improve operational efficiency, and reduce debt. We're

delivering on all three. That disciplined execution gives us confidence as we move into the

second half and beyond.”

ENDS

For all enquiries, please email investor@oceaniahealthcare.co.nz or phone 0800 333 688.

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)

Updated as at March 2025


Unaudited interim financial statements accompany this announcement.


Results for announcement to the market

Name of issuer Oceania Healthcare Limited

Reporting Period 6 months to 30 Sept 2025

Previous Reporting Period 6 months to 30 Sept 2024

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$131,632 (1%)

Total Revenue $131,632 (1%)

Underlying earnings before

interest, tax, depreciation

and amortisation

$41,509 7%

Net profit/(loss) from

continuing operations

$4,942 129%

Total Comprehensive

Income

$40,393 241%

Interim/Final Dividend

Amount per Quoted Equity

Security

Not applicable

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security (in

dollars and cents per

security)

$1.57 $1.51 (March 25)

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Please refer to attached documents (consolidated financial

statements and interim report, media release and results

presentation).

Authority for this announcement

Name of person


authorised

to make this announcement

Kathryn Waugh

Contact person for this

announcement

Kathryn Waugh

Contact phone number 0800 333 002

Contact email address Kathryn.waugh@oceaniahealthcare.co.nz

Date of release through MAP


21 November 2025

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.